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Osteoporosis is diagnosed by assessing the bone mineral density (BMD) of the trabecular
bone, and has previously been characterized with dual-energy x-ray absorptiometry (DXA) or
single-energy computed tomography (SECT). Dual-energy computed tomography (DECT) is
able to create two three-dimensional sets of images representing the densities of two materials
in a given basis pair. DECT is theoretically capable of providing a true density measurement of
trabecular bone material with the proper selection of material basis pair.
Using the rapid kVp-switching GE HD750 scanner, the concentrations of various solutes
were assessed in two-material syringe-phantoms in different experimental conditions with
DECT material density images, SECT and DXA. RMS error was used to evaluate the accuracy
of the DECT concentration measurements in air and regression was used to compare
measurements made in other scanning conditions. The effect of anthropomorphic geometry
was explored in concentric phantoms designed to model bone. The sensitivity of DECT, SECT,
and DXA to changes in bone composition was compared. The correlation between different
basis pair decompositions was evaluated. Finally, the correlation between DECT concentration
measurements and DXA areal BMD (aBMD) measurements was assessed and used to
develop a methodology to convert DECT concentration measurements to aBMD
measurements.
The RMS error of DECT concentration measurements made in air ranged from 9-244%.
Measurements of concentration made off-isocenter or with different DECT techniques were
v

found to have a small (~5%) effect, but scattering conditions resulted in a reduction of 8-27%
with similar trends observed in SECT data. In concentric phantoms, higher-attenuating material
in the outer chamber increased measured values of the inner material for all measurement
methods. DECT measurements had the highest sensitivity (2 mg/mL K2HPO4). Different DECT

basis pairs were nearly perfectly correlated (R21). This was exploited to demonstrate a strong

correlation (R2 = 0.988) between measured K2HPO4 concentration and DXA aBMD for different

two-material phantoms. The relationship of DECT aBMD and DXA aBMD was highly correlated
(R2 =0.983) but the limits of agreement (-0.16 to 0.57 g/cm2) were relatively large compared to
clinical utility.
This study suggests that corrections to output DECT concentration measurements may be
necessary for clinically acceptable aBMD or trabecular BMD values.
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1. Motivation
Osteoporosis is defined clinically as a measured bone mineral density (BMD) that is more
than 2.5 standard deviations below the mean value for a reference population of healthy “young
adults” aged 30-40 of the same gender and race imaged at the same site (1–3). This reduction
in BMD results in a lower yield strength than normal bone, which translates to an increased
fracture risk for patients (4,5).
Dual Energy X-Ray Absorptiometry (DXA) is the current gold standard for assessing BMD.
The DXA scanner outputs an areal BMD (aBMD) with units of g/cm2 rather a true bone mineral
density. Another modality that has been used for measuring BMD, although less frequently in
the clinic, is single-energy computed tomography (SECT), which uses a single x-ray tube
potential and measures tissue attenuation in Hounsfield units (HU). SECT may allow
differentiation of trabecular bone from cortical bone, which is not possible with DXA. SECT
used to make quantitative measurements of BMD using a reference phantom is referred to as
single energy quantitative computed tomography (SEQCT). As a 3D technique, SEQCT may
not be as susceptible as DXA to variations in measurement with bone size. However, SEQCT
is susceptible to beam hardening artifacts, patient scatter, and the presence of fatty marrow
which can be mistaken for reduced BMD (6–8).
Dual energy quantitative computed tomography (DEQCT) uses two x-ray tube potentials
and provides a three-dimensional dataset like SECT but the use of two effective beam energies
could theoretically allow for correction of beam hardening artifacts seen in SEQCT (9). More
importantly, DEQCT also has the ability to identify the composition of a given voxel instead of
only the net attenuation, potentially allowing more accurate assessment of bone composition.
DEQCT was first implemented in the late 70’s but in the past relied on two sequential singleenergy scans on a conventional CT scanner and costly image preprocessing techniques.
Additionally, the propagation of errors in data collected at two different energies rather than one
reduced the reproducibility of DECT relative to SEQCT. A commercial DECT scanner is now
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available that creates a dual-energy image with a single rotation utilizing a rapidly switching
voltage across the cathode that results in a rapidly changing kVp (HD750, General Electric
Medical Systems, Milwaukee, WI) and provides a ready-to-use software package capable of
processing the dual-energy data (GSI Viewer, GEMS). This software offers the ability to
decompose the signal from each voxel into the density of two user-defined materials assuming
only those materials are present; for example, iodine and water. The two-material
decomposition pairs are created by uploading a table of mass attenuation coefficients for the
appropriate materials to the GSI Viewer software. Such a mapping has the potential to
accurately assess BMD by modeling trabecular bone in terms of bone mineral (HA) and soft
tissue, reducing the errors in SECT measurements.
However, the performance of the material decomposition feature of the rapid-kVpswitching DECT scanner has not been investigated extensively. There have to date not been
any detailed studies investigating the performance of the DECT scanner using material
decomposition to characterize bone composition. The objective of this study is to quantitatively
investigate the sensitivity of GSI material decomposition images to known changes in the
composition of several two-material samples in a variety of conditions and to evaluate its
potential to assess BMD.

2

2. Introduction
2.1

Osteoporosis and Bone Mineral Density

Human bones are comprised of two distinct compartments. The outer cortical
compartment consists mostly of a dense tissue comprised of calcium hydroxyapatite (HA) and
collagen, often referred to as “bone mineral” or “bone material.” The cortical bone forms a shell
around the inner trabecular bone, also known cancellous bone. Trabecular bone consists
primarily of bone mineral, red marrow, which produces blood cells, and yellow marrow, which is
mostly fat. Bone mineral density (BMD) is the amount of bone material in a given volume of
bone, typically per cubic centimeter.
Osteoporosis is defined as “a disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a
consequent increase in fracture risk (10).” Osteoporosis is defined clinically as a measured
bone mineral density or bone mineral content that is more than 2.5 standard deviations below
the mean value for a reference population of young adults of the same gender and race imaged
at the same skeletal site (1,2). The standard deviation from the mean value is known as the Tscore. A similar metric is the Z-score, for which the reference population is the patient’s own
age group. The mean BMD for healthy women can vary by as much as 30% between reference
populations (11). Bone mineral loss is known to increase with age, at greater rates in women
than men (12–15). The normal incidence of osteoporosis increases with age, with 5% of
women in western populations aged 50-54 estimated to have the disease, and up to 60.5% of
women aged 85 or older (1). In postmenopausal women, osteoporosis is attributed to reduced
estrogen levels. One action of estrogen is to partially block the resorption of bone stimulated by
parathyroid hormone (16,17). In both women and men, bone loss may also result from a
reduction of calcium absorption in the gut from dietary sources beginning in ages 55-60 and 6570 respectively and low rates of new bone formation (12,18). Bone fractures and spinal
compression are associated with osteoporosis, and it is therefore considered a disease (12).
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While osteoporosis is a natural consequence of aging, there are several other known causes of
reduced bone mineral (19,20). One of these is an increased risk of bone mineral loss
secondary to some forms of cancer treatment (21–23).
While there are many factors proposed to be associated with fracture risk (2,24,25), the
reduced bone mineral density (BMD) associated with osteoporosis is thought to be most
predictive (2). Bone mineral density is defined as the amount of bone mineral (HA) “per unit
volume of the organic bone matrix (3).” The BMD of osteoporotic bone is reduced primarily in
the trabecular compartment (26,27) due to the larger surface area to volume ratio and
metabolic activity (28,29).
Trabecular bone in patients diagnosed with osteoporosis is known to have similar bone
material composition and density to normal bone; it is the trabecular bone volume (TBV) that is
reduced through loss of entire structural elements (4,14,27,30). This reduction in TBV results in
a lower yield strength than normal bone in mechanical stress tests and severe changes are
associated with compression fractures (1,4,5,30). The decrease in TBV coincides with an agerelated increase in fat in the marrow, although the effects are not necessarily related (8,13,31–
35).
A number of different anatomical sites have been proposed and investigated for the
assessment of trabecular BMD for fracture risk. Numerous studies have supported the
recommendation that BMD is best assessed at the anatomical site which is thought to be at risk
of fracture (15,36,37). Currently the lumbar spinal vertebrae are one of the most frequently
monitored sites of BMD. This is in part because the lumbar spine is particularly prone to
fracture; in osteoporosis these fractures are associated with an increased risk of hospitalization
and mortality (38). The lumbar spine is also preferred because of the large proportion of
trabecular bone in the lumbar vertebrae relative to the rest of the skeleton. Correspondingly,
the lumbar spine experiences a larger decrease in BMD in osteoporosis (15,39).
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2.2. Measurement of Bone Mineral Density
Measurement of trabecular BMD demands a methodology that is accurate, repeatable,
sensitive, and correlated with probability of fracture (2,40). Numerous methods for assessing
BMD have been developed since 1964 (41). Three technologies of interest in this investigation
are dual-energy x-ray absorptiometry (42), single-energy computed tomography (43,44), and
dual-energy computed tomography (45).
2.2.1. Dual Energy X-Ray Absorptiometry
Dual Energy X-Ray Absorptiometry (DXA) is the current gold standard for assessing
BMD. The modality gained rapid acceptance; a study by Intenzo et al. found that four times as
many Medicare patients had a DXA examination performed in 2002 as in 1996 (2,195,548 vs
510,105), an increase they attributed to “demographics, heightened public awareness of
osteoporosis, and advances in therapy (46).” DXA is favored because it is non-invasive and
precise, with a reported 0.5-2% coefficient of variation (CV) for posteroanterior (PA) lumbar
spine measurements (47). The DXA scanner creates a radiograph with two x-ray beams
generated from bremsstrahlung radiation at two different peak tube potentials (kVps). In the
DXA implementation by Hologic (Hologic, Bedford, Massachusetts), the x-ray source switches
between high and low kVp resulting in polychromatic beams with high and low effective
energies (48) that are attenuated by soft tissue and bone according to the Beer-Lambert law
and the energy-dependent mass attenuation coefficient ((/). In principle, the two different
effective energies allow the determination of the areal density * of one material (bone, +)

without contribution of the other (soft tissue, ,) from the integrated high and low-effective

energy x-ray beam transmissions -. and -/ , as illustrated in the DPA equation (49) (Equation
2.2.1-5) derived below:
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are known from the effective energy of each beam
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and the composition of bone mineral (hydroxyapatite) (50). The ratio ?
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is calculated as

=/ /=. either for each scan line or averaged over all regions containing only soft tissue (50,51),
since the composition of the soft tissue is not known. At MD Anderson, most DXA examinations
include an anteroposterior (AP) measurement of the lumbar spine. The typical screening
examination is vertebrae L1-L4 and each femoral neck.
The widespread use of DXA has resulted in a large body of normative data from which
an individual diagnosis of osteoporosis can be made (11,52–58). Despite its ubiquitous use,
however, DXA has an important drawback. The scanner outputs a bone mineral “density” with
units of g/cm2, which is not a true bone mineral density but in fact an estimate of bone mineral
content within a given areal projection. This is often referred to as an areal bone mineral
density, or aBMD. Because it is not a true volumetric density, an aBMD measurement is
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necessarily an inaccurate measurement of true BMD. Additionally, although the quantity of
interest is BMD of the trabecular portion of the bone, due to the two-dimensional nature of DXA
imaging cortical bone mineral is incorporated into the aBMD as well. As a result, the sensitivity
of DXA is theoretically reduced, which impacts its effectiveness as a screening modality (58).
2.2.2. Single-Energy Computed Tomography
Single energy computed tomography (SECT) is an alternative noninvasive method for
quantitative bone analysis (40). Like DXA, SECT images are produced by integral
measurements of x-ray attenuation in tissue. A computed tomography (CT) scanner creates a
three-dimensional image dataset from the rotation of an x-ray tube and detector (x, y axes) and
patient translation (z axis), most often using a filtered back-projection reconstruction in which
each beam profile is deconvolved with a sharpening kernel and then superimposed in image
space over 360 degrees (59,60). The resulting images are attenuation maps defined by the
characteristic linear attenuation coefficient (µ) of the tissues in the field of view (FOV). Each
volume element or “voxel” of the image is associated with a Hounsfield unit (HU) (also called
CT number) that is defined as
CDE, &, ,   1000 !

>F,G,H,I>FJ
>FJ

Equation 2.2.2-1

where (EK is the linear attenuation coefficient of water. Because µ is a function of energy (E),
SECT acquisitions with different kVps will yield different HU for the same tissue.
While trabecular BMD is sometimes assessed in terms of the average HU in a region of
interest (ROI) (61,62), typically for BMD assessment the CT device is calibrated with a known
standard to output units of true density (usually mg/cm3 or mg/mL). This approach is commonly
referred to as quantitative computed tomography (QCT).
Single-energy QCT (SEQCT) for the assessment of bone composition has been in use
since 1976 (43,44). Historically, SECT measurements were calibrated with known
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concentrations of dipotassium phosphate (K2HPO4) in water (26,27,63–65). Dipotassium
phosphate is a useful substitute for bone material due to its similar effective atomic number,

physical density, and linear attenuation coefficient (F for effective energies in the range of CT,

as well as its solubility in water (63,66). Solid phantoms of varying concentrations of HA in
water-equivalent plastic have also been used (65,67). In QCT studies investigating the
influence of fat in the marrow space on measurements, ethanol has often been used as a fat
substitute (33,66,68,69) due to its similar mass attenuation coefficient and its solubility in water.
Water-soluble materials allow for completely uniform phantom composition assuming they do
not precipitate out of the solution.
SEQCT outputs a true volumetric bone mineral density (vBMD), a potentially major
advantage over DXA. The three-dimensional nature of SECT data also allows for differentiation
between the trabecular and cortical compartments of bone. The potential for bone densitometry
measurements with CT was realized not long after the introduction of the device (43,44,70).
Within its first decade, SECT became established as a useful alternative to single and dualphoton absorptiometry, planar imaging predecessors of DXA that used radioisotopes rather
than x-rays, for the assessment of bone mineral density (71). SEQCT bone mineral
assessment available in the mid-90’s had precision errors (CVs) of 2-4% (40); modern-day
SEQCT with multislice helical scanners has improved this to a 1.4% “best case” precision error
and a 3.6% “worst case” error, with a routine measurement estimated to have a precision error
of 1.8% (72). SEQCT is generally more sensitive to changes in bone mass than projection
technologies (40,73). In a cross-sectional study of 108 postmenopausal women conducted by
Gulgielmi et al., SEQCT estimated a rate of bone loss in the lumbar spine over four times
greater than the rate estimated by PA DXA (1.96% vs 0.45%) (74). The same study also found
that SEQCT was a significant predictor of osteoporosis in the lumbar spine, but PA DXA was
not. In general, SEQCT BMD has been found to be at least as predictive of fracture risk as AP
DXA aBMD in the lumbar spine for postmenopausal women (25).
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Despite the demonstrated utility of SEQCT, there are a number of disadvantages that
prevent it from being the preferred screening method for generalized fracture risk. Although
QCT may be implemented on existing SECT scanners, a DXA scanner is less expensive to
acquire and operate and has no other demands placed on it other than the assessment of
BMD. In addition, a SEQCT spine examination delivers 1.2-120! more radiation dose to the
patient than a DXA spine examination (0.016-1.5 mSv depending on type of examination for
SEQCT vs. 0.013 mSv for DXA) (75). SEQCT is also a less precise modality than DXA due to
the more numerous scan parameters, in which variations contribute to the total error (72,76).
While the true density measurements of vBMD are more accurate characterizations of
bone tissue than DXA aBMD, SEQCT suffers from other sources of inaccuracy. A well-studied
limitation on SEQCT measurements is beam hardening (6,77,78), a phenomenon that results
from the polyenergetic x-ray spectrum used to produce the images (the effect is present in DXA
as well (79)). As the polyenergetic beam travels through a patient, lower-energy x-ray
components of the beam are attenuated. The result is a net shift upward in the effective energy
of the beam (“hardening”), resulting in lower attenuation measurements than expected.
Because of these lower HU measurements, beam hardening artifacts affect SEQCT primarily
by reducing the observed vBMD (64,80). Beam hardening can be addressed and corrected in a
number of ways in SEQCT, including empirical modeling (80), calculations based on assumed
materials present in the image (81), and reference phantoms (6). However, none of these
methods are completely capable of removing beam hardening artifacts in an individual
examination.
SEQCT measurements are also confounded by the effects of x-ray scatter. In the range
of effective energies used in CT examinations, “scatter” refers primarily to Compton scatter,
which has the dominant interaction cross section or probability of interaction in water
(compared to the photoelectric effect, which has the next largest cross section). Compton
scatter is an inelastic process in which an x-ray photon collides with a free charged particle (in
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a patient, usually an electron) and a scattered x-ray photon with reduced energy leaves the
collision site at an angle to the original path. In CT imaging, this scattered x-ray photon is
detected by the imaging equipment but the signal does not correspond to the original
(“primary”) beam path, so it appears as noise and degrades the contrast of the resultant image
along with other background noise sources.
Another consequence of scatter was illustrated by Glover (82). The total intensity -L of
radiation at the detector can be represented as a sum of the contributions of the intensity of the
primary beam -M and of the total scattered radiation -N :
-L  -O  -@ .

Equation 2.2.2.-2

The detected x-ray attenuation is logarithmically transformed during the reconstruction process,
so equivalently
log-L   log -O Q1  R6 T.
R

S

Equation 2.2.2-3

If the scatter to primary ratio -@ /-M is much smaller than 1, eq. 2.2.2-3 may be re-written:
R

UL  UO ' R6  UO  U@
S

Equation 2.2.2-4

where UL V ' log -L , UO V ' log -O and U@ V -@ /-O . The result is the measured total logarithmic
attenuation UL is reduced from the expected measurement by an amount equivalent to the

scatter to primary ratio. When the x-ray beam passes through a highly attenuating region, there
is a much greater decrease in -O than -@ so a noticeable decrease in HU from the expected
value will be observed. An example is when a flat x-ray beam with no primary attenuator
encounters a homogenous water-filled cylindrical phantom meant to represent a patient. The
beam is unevenly attenuated by the patient and so a “cupping” artifact is observed, in which the
HU measured in the center of the phantom is less than HU measured around the edges. This
effect is compensated for in CT scanners with the use of a bowtie filter, an attenuating object
shaped in such a way to ensure the beam is roughly uniformly attenuated along its entire
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profile. Different-sized patients necessitate different-sized bowtie filters. This selection is never
exact and as a result patient size is known to affect SEQCT measurements (7,83,84).
The accuracy of SEQCT is perhaps most dramatically affected by the amount of fat in
trabecular bone. Because SEQCT is calibrated with varying compositions of bone mineral
equivalent material in water and because fat is less attenuating than water (typically -50 to -100
HU compared to 0 HU for water), the presence of fat in the marrow space causes a systematic
error in SEQCT measurements. Because marrow makes up approximately 75-80% of
trabecular bone, and fat approximately 25-75% of marrow, the systematic error can be large
(85). In addition, the presence of unknown quantities of fat causes an underestimation of vBMD
of 10-30% at 80 kVp and 20-40% for tube potentials up to 130 kVp (8). An adjustment of
SEQCT measurement can be made based on normative data on fat content over age and the
underestimation of vBMD over fat content (86). However, individual variation in vertebral fat still
accounts for 12-24% of the residual inaccuracy at 80 kVp and 30-40% up to 130 kVp.
2.2.3. Dual Energy Computed Tomography
Dual-energy computed tomography (DECT) has the potential to overcome the
limitations on accuracy of SECT. Dual-energy computed tomography, first proposed
simultaneously with SECT (70), utilizes the same imaging methodology as single-energy
computed tomography, but with acquisitions at two effective x-ray energies instead of one.
When attenuation data have been acquired at two different effective energies, either a
preprocessing (projection based) technique (9) may be applied to the raw data or a
postprocessing (image based) technique (87) may be applied to the resulting image sets to
create new images that are able to distinguish between two different materials in a given voxel
rather than providing a net attenuation measurement. A preprocessing technique is
advantageous because it is in theory free of beam hardening artifacts due to the decomposition
functions used (88,89). However, preprocessing is technically challenging and requires access
to the raw data; until recently the technique was limited to a few research centers (90,91).
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The most studied preprocessing technique is based on the work of Alvarez and

Macovski (9). The method relies on the principle that the linear attenuation coefficient (E of a
given material varies with the effective energy of an x-ray beam according to a linear
combination of the photoelectric effect and Compton scattering. The cross section of the
photoelectric effect is inversely proportional to the third power of effective energy (E " ,

whereas the cross section of Compton scattering is described by the Klein-Nishina formula

WXY E, as described in the paper. The linear attenuation coefficient in a given (multislice) CT
image, through empirical testing, is approximated by the function


(&, , E  Z &, ,  F [  Z$ &, WXY E.

Equation 2.2.3-1

The coefficients Z and Z$ depend on the atomic number \, mass density ), and atomic weight

] of the material, such that

?

Z  _ ` \ a
b
^
?
Z$  _$ ` \

,

Equation 2.2.3-2

where _ and _$ are empirical constants, c  4, and all parameters except for c are dependent
on the location in the image (x, y). An individual photon in the x-ray beam of the CT scanner
measures the line integral of (&, , , E, that is,


d (&, , , E ef  ] F [  ]$ WXY E

Equation 2.2.3-3

where
]  d Z &, ,  ef and ]$  d Z$ &, ,  ef .

Equation 2.2.3-4

If two measurements were made with x-rays beams of two different energy spectra , and ,$ ,
then the two different intensity measurements - can be obtained:
g
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b

Equation 2.2.3-5

where h is the total measurement time and - is the total energy. Through these two intensity

measurements, the coefficients ] may be derived. If two materials (a basis pair) are assumed

to be in a given voxel or conversely if a constant density is assumed, the density (and for most
materials, the electron density) or material properties (atomic number, mass) can be obtained.
The former method can be used to produce two material decomposition image sets, where the
voxels in each set represent the density of one material assuming the other is present.
Separation of the spectra is important for dual-energy reconstruction; the lower-energy beam
should be attenuated a relatively large amount by the more material sensitive photoelectric
interactions, while the higher-energy beam should be dominated by Compton scattering; in
principle greater separation between the two images gives greater material discrimination.
However, the more the lower energy beam becomes attenuated, the more the signal to noise
ratio decreases (92).
It is important to note that the equations in (13) are non-linear and cannot be solved
exactly. The choice of reconstruction function will impact the accuracy of any preprocessed
DECT measurement. It is also important to note that the Alvarez and Macovski method does
not address the problem of scattered radiation (9). It is also important to note that unlike in DXA
dual-energy reconstructions, the two materials used in DECT material decomposition image
sets are input by the user and assumed to be known. Density for each basis pair material is
derived solely from first principles. DXA, by contrast, only assumes one material is known (HA)
and applies an empirical correction to the areal density based on indirect measurements of the
second material (soft tissue). In this way, DXA essentially normalizes the density measurement
for each individual patient whereas no normalization is applied in DECT acquisitions. While
DXA aBMD is assessed daily with a quality control (QC) phantom provided by the
manufacturer, there is currently no similar calibrated standard for assessing DECT density
measurements.
In principle, there are a number of ways to implement DECT acquisition. The simplest
method to obtain two spectra is to simply repeat a SECT scan twice at different kVps (93,94).
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However, due to the sequential nature of the scans, this method is prone to image artifacts
caused by patient motion in a clinical situation. An implementation involving a single scan is
preferred. In one proposed implementation, a split filter of differing thickness is placed over the
tube window such that the beam on one side of the filter passes through more attenuating
material and is harder than the beam on the other side (95). In another, the detector is split
such that the two sides are more sensitive to higher and lower-energy photons (96). Besides
poorer discrimination between Compton scattering and the photoelectric effect, these
(research) methods also prevent single-energy acquisitions on the same scanner. One solution
is an implementation in which two sources set to two different kVps are set at 90° from one
another and rotated around the patient simultaneously paired with two detectors (97). The
current most commonly used implementation method has the disadvantage of reducing the
effective FOV of the scanner when used for DECT due to the small size of one of the detectors
used (98) and also relies on postprocessing imaging techniques that do not compensate for
beam hardening (89). Another implementation involves a single source that rapidly switches
between two kVps paired with a single detector (99,100).
One of the first applications of DECT was quantitative assessment of bone mineral
(DEQCT) (45) by Genant et al. using sequential scanning and postprocessing. A follow-up
study conducted a much more in-depth characterization of the technique (68). Genant and
Boyd measured the CT number and fraction K2HPO4 of varying solutions of K2HPO4 in water
and K2HPO4 –water–ethanol in single-chamber cylinders to simulate cortical and trabecular
bone and in concentric cylinders to simulate bone geometry. The two chambers (trabecular and
cortical) of the concentric phantom were measured separately and as an integral. The
investigators found excellent correlation of CT number with K2HPO4 in both the solid and
concentric cylinders and lower than expected CT numbers in the middle of cylinders with thick
cortical bone, indicating beam hardening error. In measurements of the K2HPO4 concentration,
DEQCT was found to have greater accuracy, far less susceptible to ethanol concentration, but
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less precision. The investigators concluded that DEQCT might be more useful for diagnosis
and SEQCT for follow-up.
Many subsequent studies confirmed these results (76,85,94,101). In the late ‘80s,
DEQCT studies were reporting a standard error of the estimate of 3-6% in normal women and
6-10% in older women, compared to 6-9% and 10-15% respectively with SEQCT, but a three to
fourfold reduction in precision and a doubling of dose (73,102). Research in DEQCT for vBMD
measurement mostly ceased by 1996, when Genant et al. published a literature review on
noninvasive bone analysis that briefly concluded the poorer precision and higher dose of the
technique made it suitable only for research applications (40).
Recently, interest in DECT has re-emerged with the advent of the first commercial
DECT scanner in 2006 (97). A variety of studies have been published on the potential clinical
application of these scanners (103–105). However, we are not aware of any studies to date
assessing the capability of these new DECT scanners for characterizing BMD. A commercial
DECT scanner with rapid kVp switching (rsDECT) and dual-energy preprocessing modeled
after the methods of Alvarez and Macovski is now available (100). The GE HD750 (General
Electric Medical Systems, Milwaukee, WI) includes pre-packaged image analysis software
called GSI Viewer (General Electric Medical Systems, Milwaukee, WI) that allows for twomaterial decomposition image sets to be created based on user-defined material basis pairs.
The purpose of this present study is to characterize this feature of the scanner and its potential
for vBMD measurement.
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2.4. Hypothesis and Specific Aims
Hypothesis: Rapid-kVp-switching dual energy computed tomography (DECT) is capable of
producing material density images with an accuracy better than 95% which are more sensitive
to changes in bone-equivalent material than dual-energy absorptiometry (DXA) and can be
related to DXA areal bone mineral density (aBMD) measurements to distinguish osteoporotic
from normal bone within a 95% confidence interval.
Specific Aim I: To quantitatively investigate the performance of material density
concentrations, SECT, and DXA to known changes in the composition of several twomaterial samples.
•

Subaim 1: To determine the accuracy of DECT material decomposition when
characterizing two-material samples using the constituent material
decomposition basis pairs and to compare the performance and sources of
variability of DECT material density images, SECT, and DXA for a variety of
imaging conditions.

•

Subaim 2: To compare the performance of DECT material density images,
SECT, and DXA in a concentric phantom designed to simulate the geometry of
bone.

•

Subaim 3: To evaluate the relative sensitivity of DECT material density images,
SECT, and DXA to changes in K2HPO4 concentration.

•

Subaim 4: To quantitatively investigate the correlations between several
constituent and non-constituent DECT basis pairs for given two-material
samples.

Specific Aim II: To quantitatively investigate the relationship between DECT material
density concentrations and DXA measurements and compare a DECT and SECTderived aBMD with DXA.
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•

Subaim 1: To analyze the correlation of DECT concentration measurements
using the K2HPO4-water basis pair with DXA aBMD measurements.

•

Subaim 2: To develop a methodology to calculate DECT and SECT-based areal
bone mineral density in g/cm2 of HA and investigate the correlation of each to
DXA-based aBMD.

17

3. Specific Aim I: Performance of DECT and Measurement Method Comparison
3.1. Subaim 1: Accuracy of DECT and Comparison of Measurements
3.1.1. Material Decomposition Accuracy
3.1.1.1. Materials and Methods
A characterization of the accuracy of material density image-derived concentration
measurements was sought. Syringe-phantoms were designed to assess the accuracy of the
material density images in the simplest case of decomposing two-material samples into their
constituent basis pairs. Seven 30 mL solutions of iodinated contrast (Optiray 320, Mallinckrodt
Pharmaceuticals, St. Louis, MO) and water, ethanol and water, dipotassium phosphate
(K2HPO4) and water, and a 10 gm% K2HPO4 and water solution plus denatured ethanol were
prepared in 60 mL syringes with a diameter of 2.5 cm. The materials were selected due to their
ubiquitous use as CT contrast (Optiray 320), and as bone (K2HPO4) and fat (ethanol)
surrogates in CT research. The syringe-phantoms containing both 10 gm% K2HPO4 solution
and ethanol were constructed (106) to model the composition of trabecular bone, containing
both fatty yellow marrow and bone material.
The concentration of each solute (Optiray 320, ethanol, and K2HPO4) varied in 5% by
volume increments from 0-30%, for a total of 21 solutions. For the additional seven 10 gm%
K2HPO4 solution-ethanol syringe-phantoms, the ethanol concentration was varied in 5% by
volume increments from 0-30% representing progressively more yellow marrow. However, for
the remainder of this paper the 10 gm% K2HPO4 solution is considered the “solute” since,
representing bone material, it is the material of interest. These concentrations were selected to
give a broad range of material densities for each solute, particularly for the K2HPO4, which
nears its precipitation point at 30% concentration.
In preparing solutions containing K2HPO4, the K2HPO4 powder was weighed on a gram
scale with an approximate uncertainty of ±0.001 g provided by the manufacturer. Distilled water
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and ethanol were measured out in 5 and 1 mL volumetric pipettes with an estimated
uncertainty of 0.01 mL each. K2HPO4 is known to create an excess volume when dissolved in
water (107) so the concentration was adjusted based on volumes measured with the syringes.
The uncertainty in volume from syringe measurements (± 0.05 mL) was translated to error bars
in subsequent analysis (Section 3.1.1.2.1). The excess volume effect is also known for ethanol
added to water, and the concentration was adjusted according to fourth-order polynomial fit to
partial volume tables found in Benson and Kiyohara (108). This effect is notably much smaller
than for K2HPO4. Excess volume data was not available for Optiray 320-water and K2HPO4water-ethanol solutions, but visual assessment of the syringe-phantoms determined that
volume corrections were not necessary.
Scans were acquired with the GE HD750 dual-energy CT scanner using the GSI-6 dualenergy protocol (medium body filter, rotation time 1s, beam width 40 mm, CTDIvol 33.43 mGy).
Each syringe-phantom was placed in the central bore of an electron density phantom (Model
62, CIRS, Norfolk, VA), which measures 13 x 2 x 10.6 in. (33 x 5.1 x 27 cm), with the portion
containing the solution protruding in air and the central bore aligned at isocenter (Figures 1-2).
Eight 5 mm images were acquired and reconstructed using the GE GSI viewer software into
material density maps using the constituent basis pair (for example, Optiray 320 and water).
The mass attenuation coefficients for each material in the basis pair loaded to the GSI software
were taken from the NIST database using XCOM (109), except for water, which was available
as a pre-determined material. Optiray 320 was programmed as a mixture according to the
composition listed in the package insert. For each syringe-phantom, the mean solute
concentration and standard deviation was recorded from a circular region of interest (ROI) of
250-259 mm2 drawn in the center of the transaxial area of the syringe (Figure 3) in the central
image (image 4 or 5).
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Figure 1: CIRS 62 electron density phantom, pictured with included tissue-equivalent inserts
placed in bores. The inner “head” portion can be removed or it can remain in place to simulate
a “body” measurement.

Figure 2: Configuration of materials used for in-air DECT and SECT measurements. Each
syringe-phantom was inserted in the central bore of the electron density body phantom with the
solution protruding in air. Eight images that span the solution volume were acquired, and a
measurement was made on the central image (image 4 or 5) as shown.
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Figure 3: Illustration of procedure for making material density measurements in GSI Viewer.
The image shown is a material density map; a circular ROI is drawn in the cross-section of the
syringe-phantom.

For comparison, immediately following the DECT scans, axial SECT images were
acquired sequentially at 120 kVp/150 mA and 80 kVp/200 mA with 1s tube rotation time and
the medium body filter selected. The corresponding mean and standard deviation of the CT
number were measured in the GSI Viewer software and recorded for all image sets using the
same ROI size range and approximate position as the concentration measurements. The
syringe-phantoms were also scanned individually with a DXA scanner (Discovery, Hologic,
Bedford, MA) with each syringe-phantoms placed horizontally between five 3/8 in. (9.5 mm)
thick PMMA slabs on top and three slabs beneath to simulate patient scattering conditions in a
lumbar spine measurement (Figure 4). aBMD measurements were made using vendor supplied
software in lumbar spine analysis/subregion array spine mode by manually drawing a
rectangular ROI over the central axis of the syringe-phantom to segment the “bone” region
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(Figure 5). The Hologic Discovery scanner produces x-ray beams with switching tube potentials
of 100 and 140 kVp.

Figure 4: Positioning of syringe-phantom for DXA measurement. Five 3/8 in. (9.5 mm) PMMA
slabs are placed above and three below to simulate patient scattering conditions in a lumbar
spine measurement.

Figure 5: DXA measurement of a two-material syringe-phantom with the vendor-provided
software. A "bone map" was manually drawn on the central axis. The BMD was reported in
areal density (g/cm2).
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The material density image-derived solute concentrations were compared with the
known concentrations and the data was fit with a linear regression. The Pearson’s correlation
coefficient (r) was computed. The probability of a slope of unity and the probability of a yintercept equal to 0 were determined with an f-test using GraphPad Prism 6 statistical analysis
software (GraphPad Software, La Jolla, CA). Regressions with a y-intercept consistent with 0
within the 95% confidence intervals were re-plotted with the y-intercept set to 0. The accuracy
was evaluated by calculating the total root mean square (RMS) error and the RMS error as a
coefficient of variation (CV) of the solute across all concentrations for the relevant syringephantoms. The material density image-derived solute concentrations and the known
concentrations were also compared using Bland-Altman analysis (110).
An evaluation of the different sources of variation in the DECT scanner measurements
was necessary in order to determine the accuracy of the concentration measurements from the
material density images. Four sources of variation were identified: variation in phantom
preparation (M ), variation between images in each acquisition (o ), variation between

acquisitions (p ) and random variation in concentrations across the ROI or noise (a ).

In order to estimate variation in phantom preparation, M , four 25% Optiray 320 syringe-

phantoms and three 2.5% K2HPO4 syringe-phantoms were independently prepared. These
concentrations were selected to represent estimated “worst-case” variation for the two
respective materials based on the phantom preparation method. These syringe-phantoms were
scanned with DECT using the same methodology as described for the other syringe-phantoms.
The phantom preparation variation M was not evaluated for ethanol and 10gm% K2HPO4

solution syringe-phantoms because due to the large inaccuracies observed relative to the other
syringe-phantoms, it was judged not worth the time and financial resources to obtain the

relevant data. In order to estimate variation between images, o , the standard deviation of the
mean was determined from DECT data in the same location on an eight-image stack of three
concentrations (10, 20, 30%) of each solute or ethanol. The two outermost images (Images 1
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and 8) for each stack were found to have partial volume artifacts with air and the electron
density phantom respectively and were not included in the analysis. To estimate variation

between scans, p , a single 25% Optiray 320, a single 2.5% K2HPO4 syringe-phantom, and the
25%-ethanol 10 gm% K2HPO4 solution syringe-phantom were scanned three times on three
separate dates using the methodology described earlier in this section, and the standard

deviation of the mean concentration was determined. The p was not evaluated for ethanol.

Finally, the noise (a ) of each measurement of all Optiray 320, ethanol, K2HPO4, and 10 gm%
K2HPO4 solution concentrations was defined as the standard deviation of the mean. The total
standard deviation L of each mean concentration was then calculated from combining these

four standard deviations in quadrature. The phantom preparation variation M was not included
in the total variation for any syringe-phantom containing only water.
For comparison, the same method was used to calculate each variation for SECT and

DXA measurements, using the same syringe-phantoms to calculate M . The differing nature of

DXA aBMD measurements required only M and p to be evaluated. DXA produces a single

image rather than an image stack and the standard deviation or variability or “variation” of the
measurement displayed is not provided by the DXA software.
3.1.1.2. Results
3.1.1.2.1. DECT Accuracy
The magnitude of each source of variation for each two-material syringe-phantom
imaged with DECT is summarized for a representative concentration in Table 1.Measurements
of the ethanol syringe-phantoms in general had the highest variation.
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Table 1: Calculated sources of variation of a solute concentration measurement in air by DECT
for a 25% concentration. The mean value and CV of the total variation are also shown for
reference. The total variation is the sum of the individual variabilities added in quadrature.

DECT Variation (Air)
Phantom Preparation (σp)

Optiray
25%
(mg/mL)
3

Ethanol 25%
(mg/mL)

K2HPO4 25%
(mg/mL)

-

10

10 gm% K2HPO4
Solution 25%
(mg/mL)
-

Image to Image (σi)

2

29

5

10

Scan to Scan (σr)

1

-

5

10

ROI Noise (σn)

4

41

3

10

Combined (σt)

5

50

13

17

Mean Value
CV (Unitless)

349
2%

451
11%

558
2%

912
2%

The data associated with the calculation of variation between images, o , is summarized
in Figure 6. The measured mean concentration across the central six images in the image
stack associated with each syringe-phantom is plotted with the associated distance from the
center of the image stack (taken as image 4). Each measurement was acquired with the ROI
placed in the same location in each individual image stack. Overall, except for ethanol-water,
the variation across the image stack was small (0.6-1%).
The ROI noise, a , was found to vary with concentration (Figure 7). A clear increase in
noise is seen in measurements made in syringe-phantoms containing Optiray 320 and K2HPO4,
but no clear trend is visible in the other two sets of syringe-phantoms. The dominant source of
variation differed between each set of syringe-phantoms.
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Figure 6: Mean concentration (mg/mL) measured in an ROI placed in the same position over
each of the middle six images of the image stack acquired for three Optiray 320, ethanol,
K2HPO4, and 10 gm% K2HPO4 solution syringe-phantoms. The CV for Optiray was 0.6%, the
CV for ethanol was 6%, the CV for K2HPO4 was 0.9%, and the CV for 10 gm% K2HPO4 solution
was 1%.
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Figure 7: The standard deviation of material density image solute concentration measurements
of each syringe-phantom as a function of the measured mean solute concentration.

Standard Deviation of Mean (mg/mL)

Standard Deviation vs. Mean of Solute Concentration
Measurements
45.00
40.00

Optiray 320

35.00

Ethanol

30.00

K2HPO4

25.00

10 gm% K2HPO4 Solution

20.00
15.00
10.00
5.00
0.00

-200.00

0.00

200.00

400.00

600.00

800.00

1000.00

1200.00

1400.00

Measured Mean Solute Concentration (mg/mL)

The material density image-derived solute concentrations of each constituent basis pair
are plotted against the known concentration of each material in Figure 8. The data were
positively correlated, and the squared Pearson’s correlation coefficients of each regression
were >0.986 (p < 0.0001) (Table 2). The significance tests (f-tests) and RMS errors are
summarized in Table 3. The f-test found the fitted slope was significantly (p < 0.05) different
from 1 for all solutes and the intercept was significantly different from zero only for ethanol. The
RMS errors for Optiray 320, K2HPO4, 10 gm% K2HPO4 solution, and ethanol, were 9%, 10%,
12%, and 244% respectively. The especially large RMS error in ethanol stems from the large
offset (~252 mg/mL) seen with ethanol-water basis pair measurements. While concentration
measurements were significantly linearly correlated with the known concentration, the average
RMS error was greater than 5% for all materials.
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Table 2: Pearson’s correlation coefficients (squared) for correlation, y-intercept, and slope of
concentration measurements on images acquired using DECT in air with the GSI-6 protocol
and the concentration of each solute or ethanol. Regressions with a y-intercept consistent with
0 within the 95% confidence intervals were re-plotted with the y-intercept set to 0.

Solute

R2

y-intercept
Slope

Slope (intercept = 0)
(mg/mL)

Optiray 320

0.995

1.08 ± 0.08

-8 ± 20

1.06 ± 0.04

Ethanol

0.997

1.30 ± 0.09

252 ± 13

K2HPO4

0.999

1.08 ± 0.04

0 ± 14

1.08 ± 0.02

0.993

1.0 ± 0.1

83 ± 90

1.12 ± 0.01

10 gm% K2HPO4
Solution
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DECT Correlation/Accuracy
1500

1000

Equivalence
Optiray 320
Ethanol
K2HPO4

500

10 gm% K2HPO4 Solution

0
0

500

1000

1500

Known Concentration (mg/mL)

Figure 8: The material density image-derived concentration value of each solute is compared to
the known concentration. A linear regression was applied for each solute. The line of
equivalence is shown for reference. Error bars on the y-axis indicate total variation for each
measurement and are too small to be visible on all but ethanol measurements. Error bars on
the x-axis for K2HPO4, represent uncertainty in known concentration based on the observed
volume but are too small to be visible in this plot.
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Table 3: Statistics for material density image accuracy evaluation. The probability that each
linear regression of the measured solute concentration vs. the known concentration has a slope
of 1 and intercept of 0 is recorded, as well as the RMS error as an absolute and percentage of
the average concentration for all syringe-phantoms of each solute. Significance in this
experiment was defined as p < 0.05.

Solute
Optiray 320

P value
(Significant
correlation)
<0.0001

P value
(Slope = 1)

P value (0
Intercept)

RMS Error
(mg/mL)

RMS
%Error

0.0157

0.3482

18

9%

Ethanol

<0.0001

0.0003

<0.0001

289

244%

K2HPO4
10 gm%
K2HPO4
Solution

<0.0001

<0.0001

0.9582

31

10%

<0.0001

<0.0001

0.065

109

12%

Bland-Altman analysis (110) is a statistical method for comparing the agreement
between two measurement techniques. The mean difference between two measurements
(bias) is evaluated and the “limits of agreement,” or the mean ± 2! the standard deviation, are
considered to be a range within which most differences would fall; variations within the limits of
agreement must be clinically acceptable. The limits of agreement are calculated for a specific
sample of the population of all measurements, so a 95% confidence interval may be calculated
for these limits for entire the population by considering the degrees of freedom of the sample,

the proper q value to give 95% confidence and the standard error f such that the interval is the
bias ± fq.

To further investigate the accuracy of the material density image-derived concentration,
we performed Bland-Altman analysis by comparing measured and expected concentrations for
all syringe-phantoms, summarized in Figure 9 and Table 4. In particular, the 95% limits of the
bias corresponding to K2HPO4 (9-43 mg/mL) are large relative to the mean change in K2HPO4
concentration equivalent that signifies osteoporosis in postmenopausal women in QCT (about
30

48 mg/mL) (111). The 95% confidence interval and limits of agreement are consistent with a
bias of 0 mg/mL only for Optiray 320. With this analysis both sets of syringe-phantoms
containing ethanol yielded especially large differences in measured concentrations from
expected.

400

D E C T M ATE R I AL D E C O M P O S TI O N AC C U R A C Y : B L AN D AL TM AN AN AL Y S I S
Optiray 320

Difference (Measured - Known) (mg/mL)

350
300

Ethanol

250

K2HPO4

200
10 gm%
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150
100
50
0
-50
0

200

400

600

800

1000

1200
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Figure 9: Bland-Altman analysis of material density image concentration measurements
compared with known concentration. Error bars on the y-axis represent the total variation of the
concentration measurements.
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Table 4: Bland-Altman analysis of material density image-derived concentration measurements
compared to the known concentration.

Solute

Average
Difference
(DerivedKnown)
(mg/mL)

Lower Limit of
Agreement of
Difference
(mg/mL)

Upper Limit of
Agreement of
Difference
(mg/mL)

Lower 95%
Confidence
Limit of
Difference
(mg/mL)

Upper 95%
Confidence
Limit of
Difference
(mg/mL)

9

-23

41

-5

24

288
26

235
-12

341
64

264
9

312
43

109

88

129

99

118

Optiray
320
Ethanol
K2HPO4
10 gm%
K2HPO4
Solution

3.1.1.2.2. SECT Linearity
The magnitude of each source of variation in an SECT measurement of a
representative solute concentration is summarized as a CV in Table 5 and Table 6. As with
DECT concentration measurements, the largest variation observed relative to the mean
concentration was in HU measurements made in ethanol syringe-phantoms.

Table 5: Calculated sources of variation of a CT number measurement in air at 120 kVp for a
25% concentration. The mean value and CV of the total variation are also shown for reference.
The total variation is the sum of the individual variabilities added in quadrature.
Optiray
25% (HU)
11

Ethanol 25%
(HU)
-

K2HPO4 25%
(HU)
10

10 gm% K2HPO4
Solution 25% (HU)
-

Image to Image (σi)

12

34

10

7

Scan to Scan (σr)

9

-

2

1

ROI Noise (σn)

56

1

8

1

Total (σt)

59

34

16

7

2144
3%

-28
-120%

813
2%

122
5%

120 kVp Variation (Air)
Phantom Preparation (σp)

Mean Value
CV (Unitless)
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Table 6: Calculated sources of variation of a CT number measurement in air at 80 kVp for a
20% concentration. The mean value and CV of the total variation are also shown for reference.
The total variation is the sum of the individual variabilities added in quadrature. Calculation of
the phantom preparation and repeat variation for Optiray 25% was not possible because the
CT number reached its maximum value so 20% concentrations were evaluated.
Optiray
20% (HU)
-

Ethanol
20% (HU)
-

K2HPO4 20%
(HU)
12

10 gm% K2HPO4 Solution
20% (HU)
-

23

14

13

7

-

-

3

1

ROI Noise (σn)

37

2

8

1

Total (σt)

43

14

20

7

2789
2%

-25
-58%

930
2%

188
4%

80 kVp Variation (Air)
Phantom Preparation (σp)
Image to Image (σi)
Scan to Scan (σr)

Mean Value
CV (Unitless)

Like DECT concentration, SECT HU was found to be positively correlated with the
concentration of all solutes at 120 kVp (R2 > 0.988) (Figure 10, Table 7) and 80 kVp (R2 >
0.913) (Figure 11, Table 8). At 80 kVp, the HU of the Optiray 320 solutions reached the
maximum value the software could record (3071), resulting in a weaker linear correlation.
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120 kVp Correlation
3000

2000

Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4
Solution

1000

0
0.0

0.2

0.4

0.6

0.8

1.0

Normalized Concentration

Figure 10: Correlation of HU measurements on images acquired using SECT at 120 kVp in air
with the normalized known concentration. The known concentration was normalized according
to the formula (value - minimum concentration)/(maximum concentration - minimum
concentration). Error bars indicate total variation for each measurement but are too small to be
visible for most measurements. The dotted lines represent the 95% confidence limits for each
regression fit to the data.

Table 7: Pearson’s correlation coefficients (squared) for correlation of HU measurements on
images acquired using SECT at 120 kVp and the known concentration of each solute.
Solute
Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4 Solution
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R2
0.988
0.997
0.998
0.995

HU
Figure 11: Correlation of HU measurements on images acquired using SECT at 80 kVp in air
with the normalized known concentration. The known concentration was normalized according
to the formula (value - minimum concentration)/(maximum concentration - minimum
concentration). Error bars indicate total variation for each measurement but are too small to be
visible for most measurements. The dotted lines represent the 95% confidence limits for each
regression fit to the data.

Table 8: Pearson’s correlation coefficients (squared) for correlation of HU measurements on
images acquired using SECT at 80 kVp and the known concentration of each solute.
R2

Solute
Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4 Solution
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0.913
0.996
0.998
0.994

3.1.1.2.3. DXA Linearity
The magnitude of each source of variation for a syringe-phantom measured with DXA
aBMD is summarized for a representative solute concentration in Table 9. The variation in
phantom preparation, though small, is a larger source of variation than the variation between
scans.

Table 9: Calculated sources of variation of a DXA aBMD measurement for a 25%
concentration. The mean value and CV of the total variation are also shown for reference. The
total variation is the sum of the individual variabilities added in quadrature.

Optiray 25%
(aBMD)

Ethanol 25%
(aBMD)

K2HPO4 25%
(aBMD)

Phantom Preparation (σp)

0.03

-

0.02

10 gm%
K2HPO4
Solution 25%
(aBMD)
-

Scan to Scan (σr)

0.01

-

0.01

0.001

Total (σt)

0.03

-

0.02

0.001

Mean Value

5.41

0.064

1.26

0.272

CV

1%

-

2%

0%

DXA Variation

The aBMD measured by DXA was also found to be correlated with solute concentration
for all materials (R2 > 0.880) (Figure 12, Table 10). The correlation was weakest for ethanol.
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Figure 12: Correlation of aBMD measured by DXA with the known normalized concentration of
each solute. The known concentration was normalized according to the formula (value minimum concentration)/(maximum concentration - minimum concentration). Error bars indicate
total variation for each measurement but are too small to be visible for most measurements.
The dotted lines represent the 95% confidence limits for each regression fit to the data.

Table 10: Pearson’s correlation coefficients (squared) for correlation of aBMD measured by
DXA with the known concentration of each solute.
R2

Solute
Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4 Solution
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0.990
0.851
0.999
0.933

3.1.1.3. Discussion
All measurement methods had less variation in the Optiray 320 phantom preparation
than in K2HPO4 phantom preparation. This result is not surprising when considering the
different preparation methods (Section 3.1.1.1). There was uncertainty introduced in the
K2HPO4-water syringe-phantoms in the weighing of the K2HPO4 and additional uncertainty
introduced during the pipetting of the water and the transfer of the K2HPO4 powder to the water.
In contrast, uncertainty was introduced in the Optiray 320 syringe-phantom preparation only
during the pipetting of the Optiray 320 and pipetting of the water; that is, there were fewer
sources of uncertainty.
The material density image-derived concentration measurements were well correlated
and increased linearly with the known solute concentration (Figure 8). SECT and DXA
measurements also showed a strong linear correlation. While material density image
measurements of syringe-phantoms containing Optiray 320 and K2HPO4 coarsely followed the
line of equivalence (intercept consistent with zero and slope only marginally different than
unity), those for syringe-phantoms containing ethanol were substantially less accurate.
Measurements of ethanol concentration in ethanol-water syringe-phantoms, though linear, had
a very large RMS error (289 mg/mL) (Table 3) and offset; indeed, a large concentration of
ethanol (260 ± 40 mg/mL) was measured even in the 0% concentration syringe-phantom,
where only distilled water was present. The ethanol-water syringe-phantoms, as well as the 10
gm% K2HPO4 solution syringe-phantoms, also had relatively large biases (Table 4).
Distinguishing between ethanol and water is evidently problematic for the material density
decomposition feature of the GSI Viewer software. This may be explained by the very similar
mass attenuation coefficients of water and ethanol within the energy range of rsDECT x-rays
(Figure 13). The effective energy of the 80 and 140 kVp beams used in the DECT acquisitions
with the medium body filter are roughly 40 and 50 keV. The mass attenuation coefficients of
water and ethanol are 0.268 g/cm2 and 0.243 g/cm2 at 40 keV and 0.227 g/cm2 and 0.216
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g/cm2 at 50 keV respectively. In comparison, the mass attenuation coefficient of K2HPO4 is
0.933 g/cm2 at 40 keV and 0.557 at 50 keV g/cm2.
Due to the poor results with the ethanol-water syringe-phantoms and basis pair, these
data were excluded from further investigation in this paper.
The large average RMS error for all solutes, even those in syringe-phantoms not
containing ethanol (Table 3), reduces confidence in absolute DECT concentration
measurements. The large RMS error for two-material phantoms of known suggests that
measurements of bone material, where the exact composition of trabecular bone varies from
patient to patient, would almost certainly see errors in accuracy greater than 5%.

Figure 13: Mass attenuation coefficient of water, ethanol, and K2HPO4 from 10-200 keV, with
the ordinate on a base 10 logarithmic scale. Data taken from NIST XCOM database (109). The
effective energies of the two beams used in DECT mode (roughly 40 and 50 keV) are
indicated.
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3.1.2. Differing Scan Parameters
3.1.2.1. Materials and Methods
To investigate the effect of various scanning conditions on the accuracy of material
density image concentration measurements, further scans of the 28 syringe-phantoms were
obtained under a variety of conditions: 1) using different a different GSI protocol, 2) in different
scattering conditions, and 3) at a location away from isocenter.
Depending on patient size, a different GSI protocol may be indicated for a hypothetical
DEQCT BMD evaluation. To assess the effect of the GSI protocol, we scanned each syringephantom with the GSI-5 protocol, which differs from the GSI-6 protocol in the bowtie filter used
and estimated CTDIvol (Table 11).

Table 11: Comparison of GSI protocols assessed in Section 3.1.2.

Protocol Type

Bowtie Filter
Size

Tube Rotation
Time

GSI-6

Body

Medium

1s

GSI-5

Body

Large

1s

Beam width
40 mm
(Axial)
40 mm
(Axial)

Estimated
CTDIvol
33.43 mGy
32.01 mGy

Differences in patient morphology and scan setup may translate into different placement
of the lumbar spine relative to isocenter of the DECT scanner in a clinical examination.
Likewise, all clinical QCT measurements of vBMD are made not in air but in scattering
conditions created by the soft tissue of the patient. To assess the effect of patient positioning,
each syringe-phantom was scanned in air with the central bore of the electron density body
phantom set 10.5 cm above isocenter (Figure 14) and compared the measurements to those
made with the syringe-phantom set at isocenter. To assess the effects of homogenous
scattering conditions, the portion of the syringe-phantom containing the two-material solution
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was placed within the central bore of the electron density body phantom while the surrounding
bores were filled with either water-filled 60 mL syringes or water-equivalent inserts (Figures 1617). To assess the effects of heterogeneous scattering conditions, the surrounding bores were
filled with water-equivalent or various tissue-equivalent inserts included with the phantom
ranging from lung equivalent (inspiration) to cortical bone equivalent (about -810 to 910 HU at
120 kVp) (Figure 17).
In a clinical environment, the weight of different patients varies greatly or the same
patient may vary in weight between exams. To assess the effect of homogenous scattering
conditions in a smaller-sized scattering environment, the head insert (7.1 in. (18 cm) diameter)
was removed from the surrounding body (13 in. x 2 in. x 10.6 in.) of the electron density
phantom and the associated bores were filled with either syringes containing water or waterequivalent inserts (Figure 18).
All scattering-condition measurements were made using the GSI-6 protocol. For
comparison, sequential axial 120 kVp/150 mA and 80 kVp/200 mA SECT scans with a 1s tube
rotation time and using the medium body filter were acquired immediately following each DECT
scan in the various scattering conditions. It was hypothesized that measurements made in
scattering conditions would have different variabilities than those made in air so a
reassessment of all sources of variation was performed of the syringe-phantoms in
homogenous scattering conditions in the body phantom using the same methods as previously
outlined in Section 3.1.1.1 (the same syringe-phantoms were used to assess phantom
preparation variation). The variation for measurements made in all scattering conditions was
estimated with the new total variabilities L .
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isocenter measurements with DECT. Right:: The syringe-phantom
syringe
Figure 14: On and off-isocenter
protrudes in air from the central bore of the electron density body phantom on and Center: set
s
10.5 cm above isocenter. Right: 120 kVp image of a K2HPO4 syringe-phantom
phantom in air 10.5 cm
above isocenter.

Figure 15:: Configuration of materials used for DECT and SECT measurements in scattering
scatt
conditions. The syringe-phantom
phantom was inserted in the central bore of the electron density body
phantom with the solution enclosed within the body of the phantom. Eight images that spanned
the solution volume were acquired, and a measurement was made on the central image (4 or
5) as shown.
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Figure 16:: DECT and SECT measurement in homogenous scattering conditions. Left: Waterequivalent inserts or 60 mL syringes filled with distilled w
water were placed within all but the
central bore of the water-equivalent
equivalent electron density phantom body to perform measurements
of each two-material syringe--phantom. Right: 120 kVp image of a K2HPO4 syringe-phantom
syringe
in
homogenous scattering conditions. The two water-equivalent
equivalent inserts can be seen at the
approximate one o’ clock and seven o’ clock positions.

Figure 17: DECT and SECT measurements in heterogeneous scattering conditions. Left:
Electron density body phantom with tissue
tissue-equivalent
equivalent inserts placed within all but the central
bore of the water-equivalent
equivalent phantom body
body. The two-material
material solution is placed within the body
of the phantom in the central bore to perform measurements of each syringe-phantom.
syringe
Right:
120 kVp image of a K2HPO4 syringe-phantom
phantom in heterogeneous scattering conditions.
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Figure 18: DECT and SECT measurements in smaller-sized homogenous scattering
conditions. Left: The outer body portion of the electron density phantom was removed and
water-equivalent inserts or 60 mL syringes filled with distilled water were placed within all but
the central bore of the water-equivalent electron density phantom to perform measurements of
each two-material syringe-phantom. Right: 120 kVp image of a K2HPO4 syringe-phantom in the
head portion of the electron density phantom. Due to the display field of view used, the image
here looks similar to the image for homogenous scattering conditions in the body phantom.

The derived solute concentration or HU for each set of measurements was compared to
the original concentration or HU measurement in air obtained in Section 3.1.1.2. A linear
regression was applied to determine the slope and y-intercept with 95% confidence intervals of
the correlation. Regressions with a y-intercept consistent with 0 within 95% confidence limits
were re-fit with a y intercept equal to 0. The Pearson’s correlation coefficient was also derived
for each fit.
3.1.2.2. Results
The magnitude of each form of variation in DECT and SECT for each set of syringephantoms in homogenous scattering conditions is summarized for a representative
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concentration in Table 12 and Tables 13-14 respectively. In general, all sources of variation
were greater in scatter.

Table 12: Calculated sources of variation of a solute concentration measurement in scattering
conditions by DECT for a 25% concentration. The mean value and CV of the total variation are
also shown for reference. The total variation is the sum of the individual variabilities added in
quadrature.

DECT Variation (Scatter)

Optiray
25%
(mg/mL)

Ethanol 25%
(mg/mL)

K2HPO4 25%
(mg/mL)

Phantom Preparation (σp)
Image to Image (σi)
Scan to Scan (σr)
ROI Noise (σn)
Total (σt)
Mean Value
CV

1
3
3
5
8
242
3%

39
314
316
377
84%

16
6
21
13
30
378
8%

10 gm%
K2HPO4
Solution 25%
(mg/mL)
12
23
97
100
687
15%

Table 13: Calculated sources of variation of a CT number measurement in scattering conditions
at 120 kVp for a 25% concentration. The mean value and CV of the total variation are also
shown for reference. The total variation is the sum of the individual variabilities added in
quadrature.
120 kVp Variation
(Scatter)
Phantom
Preparation (σp)
Image to Image (σi)
Scan to Scan (σr)
ROI Noise (σn)
Total (σt)
Mean Value
CV

Optiray 25%
(HU)

Ethanol
25% (HU)

K2HPO4
25% (HU)

10 gm% K2HPO4
Solution 25% (HU)

8

-

12

-

14
6
30
34
1491
2%

2
17
17
-33
-52%

6
10
18
25
577
4%

2
1
16
16
69
24%
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Table 14: Calculated sources of variation of a CT number measurement in scattering conditions
at 80 kVp for a 25% concentration. The mean value and CV of the total variation are also
shown for reference. The total variation is the sum of the individual variabilities added in
quadrature.

80 kVp Variation (Scatter)
Phantom Preparation (σp)
Image to Image (σi)
Scan to Scan (σr)
ROI Noise (σn)
Total (σt)
Mean Value
CV

Optiray 20%
(HU)

Ethanol
20% (HU)

K2HPO4 20%
(HU)

8
17
9
38
43
1965
2%

3
24
25
-33
-74%

23
6
13
30
40
643
6%

10 gm%
K2HPO4
Solution 20%
(HU)
3
1
24
24
111
21%

Material density image concentration measurements with the two different scan
protocols were correlated, (R2 > 0.999) and when fit to a straight line yielded an offset
consistent with 0 and a slope near unity (0.960 ± 0.005) (Figure 19, Table 15). Similarly,
material density image concentration measurements with the phantom placed on and off
isocenter were correlated (R2 > 0.999) and when fit to a straight line also yielded an offset
consistent with 0 and a slope near unity (0.954 ± 0.004) (Figure 20). Both scenarios yielded
statistically significant differences from identity, but the effect was relatively small (< 5%
discrepancy).
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Figure 19: Comparison of material density image concentration measurements performed
using the GSI-5 and GSI-6 protocols. Error bars on the x and y axis indicate total variation for
measurements made using GSI-6 and GSI-5 protocols respectively and aren’t visible for most
points.
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Figure 20: Comparison of material density image concentration measurements performed at
isocenter and 10.5 cm above isocenter. Error bars on the x and y axis indicate total variation for
measurements made on and displaced from isocenter respectively and aren’t visible for most
points. All measurements were made using the GSI-6 protocol.
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Table 15: Slope and y-intercept with 95% confidence intervals and squared Pearson’s
correlation coefficient for the linear regression comparing material density image concentration
measurements acquired using GSI-5/6 protocols and on/10.5 cm above isocenter. The yintercept with 95% confidence intervals was equivalent to 0 in the original regression in both
cases, so the data were re-fit with a regression set to intercept the y-axis at y = 0 mg/mL. The
probability of the slope of this regression being equivalent to unity was evaluated with an f-test.
Significance in this experiment was defined as p < 0.05.

Regression
GSI-5 vs.
GSI-6
Off vs. OnIsocenter

Slope

R2

y-Intercept
(mg/mL)

Slope (Intercept = 0)

p (slope = 1)

0.955 ± 0.008

>0.999

4±5

0.960 ± 0.005

<0.0001

0.957 ± 0.006

>0.999

-2 ± 4

0.954 ± 0.004

<0.0001

Scattering conditions severely (by ~26%) reduced the material density image-derived
concentration compared to measurements made in air (Figure 21, Table 16). The effect of
heterogeneous scattering conditions was not significantly different from homogenous scattering
conditions (< 1% difference). The effect of scatter in the head phantom was far less
pronounced, but still significant (~8% reduction from in-air measurements). In comparison, the
presence of scattering material also decreased the CT number relative to air at 120 (slope =
0.70 ± 0.01) and 80 kVp (slope = 0.75 ± 0.04) (Figure 22, Table 17). Again the difference
between measurements made in heterogeneous and homogenous scattering conditions was
not significant. Measurements made in the head insert did not differ as much as in the body
phantom when compared to air (slope = 0.834 ± 0.007 at 120 and 0.93 ± 0.04 at 80 kVp).

49

Table 16: Slope and y-intercept with 95% confidence intervals and squared Pearson’s
correlation coefficient for the linear regression comparing material density image concentration
measurements made in air and in various scattering conditions. The y-intercept with 95%
confidence intervals was equivalent to 0 in the original regression in all cases, so the data were
re-fit with a regression set to intercept the y-axis at y = 0. Significance in this experiment was
defined as p < 0.05.Note: Hom. = homogenous, Het. = heterogeneous.

0.994

y-Intercept
(mg/mL)
-14 ± 17

Slope
(Intercept = 0)
0.74 ± 0.02

0.76 ± 0.02

0.996

-10 ± 14

0.75± 0.01

< 0.0001

0.92 ± 0.02

0.998

-7 ± 13

0.91 ± 0.01

< 0.0001

DECT Regression

Slope

R2

Hom. Scatter vs. Air

0.75 ± 0.03

Het. Scatter vs. Air
Small Hom. Scatter vs.
Air

p (slope = 1)
< 0.0001

Figure 21: Comparison of material density image concentration measurements acquired in air
and in different scattering conditions. Error bars on the x and y axis indicate total variation for
measurements made in air and in scattering conditions respectively. The line of equivalence is
shown for reference.
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Figure 22: Comparison of SECT HU measurements acquired in air and in different scattering
conditions at 120 and 80 kVp. Error bars on the x and y axis indicate total variation for
measurements made in air and in scattering conditions respectively. The line of equivalence is
shown for reference.
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Table 17: Slope and y-intercept with 95% confidence intervals and the squared Pearson’s
correlation coefficient for the linear regression comparing SECT concentration measurements
made in air and in various scattering conditions at 120 and 80 kVp. The y-intercept with 95%
confidence intervals was equivalent to 0 in the original regression in homogenous and
heterogeneous scattering conditions in the body phantom at 80 kVp, so the data were re-fit with
a regression set to intercept the y-axis at y = 0 HU. Note: Hom. = homogenous, Het. =
heterogeneous.

SECT Regression
Hom. Scatter vs. Air
(120 kVp)
Hom. Scatter vs. Air
(80 kVp)
Het. Scatter vs. Air
(120 kVp)
Het. Scatter vs. Air
(80 kVp)
Small Hom. Scatter
vs. Air (120 kVp)
Small Hom. Scatter
vs. Air (80 kVp)

Slope

R2

y-Intercept
(HU)

Slope
(Intercept = 0)

0.70 ± 0.01

0.999

-14 ± 10

0.79 ± 0.05

0.984

-60 ± 70

0.71 ± 0.01

0.999

-15 ± 11

0.77 ± 0.04

0.982

-60 ± 60

0.834 ± 0.007

>0.999

-11 ± 7

<0.0001

0.93 ± 0.04

0.994

-50 ± 49

0.0012

p (slope = 1)
<0.0001

0.75 ± 0.04

<0.0001
<0.0001

0.77 ± 0.04

<0.0001

For the remainder of this paper, when assessing the effects of scatter on DECT and SECT
measurements, we explored only homogenous scattering conditions in the body phantom.
Figures 24-28 illustrate the magnitude of each source of variation for each measurement
method as an average CV of the mean measurement across all concentrations. Figure 23
illustrates the magnitude of the total variation for each measurement method. The magnitude of
every type of variation is highest in DECT and SECT measurements in scattering conditions
and for ethanol.
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Scan-to-Scan Variation σr
6.00%
Optiray

5.00%

K2HPO4
4.00%

10 gm% K2HPO4 Solution

3.00%
2.00%
1.00%
0.00%
DECT (Air) DECT (Scatter) 120 kVp (Air)

120 kVp
(Scatter)

80 kVp (Air)

80 kVp
(Scatter)

DXA

Figure 23: Variation between scans as an average CV of the mean measurement assessed in
DECT, SECT, and DXA for Optiray 320, K2HPO4, and 10 gm% K2HPO4 solution syringephantoms.

Image-to-Image Variation σi
20.00%
0.00%
-20.00%

DECT (Air)

DECT (Scatter)

120 kVp (Air)

120 kVp
(Scatter)

80 kVp (Air)

80 kVp (Scatter)

-40.00%

Optiray 320

-60.00%

Ethanol

-80.00%

K2HPO4

-100.00%

10 gm% K2HPO4 Solution

-120.00%
-140.00%

Figure 24: Variation between images as an average CV of the mean measurement assessed in
DECT and SECT for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringephantoms. The very large CV for ethanol measured in air at 120 kVp is mostly due to the
relatively small mean value in the denominator.
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Phantom Preparation Variation σp
4.50%
4.00%

Optiray 320

3.50%

K2HPO4

3.00%
2.50%
2.00%
1.50%
1.00%
0.50%
0.00%
DECT (Air)

DECT (Scatter)

120 kVp (Air)

120 kVp
(Scatter)

80 kVp (Air)

80 kVp (Scatter)

Figure 25: Variation in known concentration from phantom preparation as an average CV of the
mean measurement assessed in DECT, SECT, and DXA for Optiray 320 and K2HPO4 syringephantoms.

ROI Noise σn
120.00%
100.00%

Optiray 320
Ethanol

80.00%

K2HPO4
60.00%

10 gm% K2HPO4 Solution

40.00%
20.00%
0.00%
DECT (Air)

DECT (Scatter)

120 kVp (Air)

120 kVp
(Scatter)

80 kVp (Air)

80 kVp (Scatter)

Figure 26: Variation in measured mean as an average CV of the mean measurement assessed
in DECT and SECT for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringephantoms.
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Figure 27: Total variation as an average CV of the mean measurement assessed in DECT,
SECT, and DXA for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringephantoms. The very large CV for ethanol is partially due to the relatively small mean value in
the denominator.
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Total Variation σt
150.0%
Optiray 320
Ethanol

100.0%

K2HPO4
10 gm% K2HPO4 Solution

50.0%

0.0%
DECT (Air)

DECT
(Scatter)

120 kVp (Air)

120 kVp
(Scatter)

80 kVp (Air)

80 kVp
(Scatter)

DXA

-50.0%

-100.0%

-150.0%

Table 18 summarizes the scan-to-scan variation p of each measurement method for

comparison, excluding ethanol due to the large CVs. Variation p is greatest for the DECT
scanner measurements in scattering conditions (7%), while it is greatest for DXA (0.2%).

Table 18: Variation between scans as an average CV of the mean measurement across all
syringe-phantoms except for ethanol for DECT, SECT and DXA in air and in scattering
conditions.

Measurement Method Scan-to-Scan Variation σr
DXA
120 kVp Air

0.2%
0.4%
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80 kVp Air
DECT Air
80 kVp Scatter
120 kVp Scatter
DECT Scatter

0.4%
0.8%
1%
1%
7%

3.1.2.3. Discussion
While the effects of the GSI protocol used and position relative to isocenter produced
only small (< 5%) reductions (Table 15), the large reductions (~9-26%) (Table 16) in material
density image-derived concentrations obtained in scattering conditions indicates sensitivity of
these measurements to scan conditions. The reductions seem to correlate with the amount of
scattering material surrounding each syringe-phantom. Because the amount of soft tissue
attenuation will vary between patients, or a single patient may have different amounts of tissue
at different time points due to weight loss or gain, the observed variation in GSI values with
phantom size may be problematic for clinical interpretation. While dual-energy x-ray imaging
would ideally compensate for effects such as the amount of non-bone tissue, beam hardening,
and scatter, its similarity in behavior to SECT suggest certain limitations in the preprocessing
algorithm used in the GSI Viewer software. Because the indicated protocol and anatomic
positioning will differ for each patient in a clinical situation, the observed differences between
measurements made on and off isocenter and between GSI protocols contribute to the poor
accuracy, although their effect is relatively small.
Comparing the sources of variation in air and in scattering conditions, the variation
between scans was smallest for DXA (Table 9), indicating it has the most stability between
scans of the three measurement methods. DXA is known to have a low variation between
scans, which is an important reason for its status as the gold standard of bone mineral
assessment (74). In scattering conditions, DECT measurements had a relatively high variation
between scans and in scatter had the highest of the measurement methods assessed,
suggesting a potential problem for the use of DECT measurements in screening for bone
mineral loss. Because DECT data is derived from two sets of single-energy data, the sources
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of variation in each beam may act in a cumulative fashion to decrease the precision of DECT.
There is also likely to be additional variation introduced in the preprocessing basis pair
computations.
3.2. Subaim 2: Measurements in Bone Geometry Models
3.2.1. Concentric Phantom Accuracy
3.2.1.1. Materials and Methods
The objective of this study was to assess the performance of the material density
images when imaging phantoms that model the geometry of human bones. Concentric
phantoms were constructed and scanned to ascertain if there were differences in material
density image-derived concentrations under bone-like conditions relative to uniform syringephantoms. Thirteen concentric phantoms were prepared, consisting of a 5 mL cylindrical plastic
vial (diameter = ½ in. or 1.3 cm) containing a solution of K2HPO4 in water placed inside a 50 mL
plastic centrifuge tube (diameter = 3.0 cm) containing Optiray 320 solution. The lessattenuating inner solution of K2HPO4 was constructed to simulate trabecular bone, while the
more-attenuating outer solution of Optiray 320 was constructed to simulate cortical bone. Two
sets of concentric phantoms were created, each designated as (X%/Y%) where X is the
concentration by volume of K2HPO4 in the inner chamber and Y is the concentration by volume
of Optiray 320 in the outer chamber, as per Table 19 and Figure 28. One set was constructed
with the concentration of the inner solution fixed at 10% by volume and the concentration of the
outer solution increasing in increments of 5% per volume from 0-30% and the other with the
outer solution fixed and the inner solution increasing in concentration. Two concentric
phantoms (0%/0%, containing only water in each chamber, and 10%/10%) were shared
between the sets. Dual and single-energy scans were acquired with the concentric phantom
placed in the electron density body phantom in air and in scattering conditions as described in
Section 3.1.1.1 (Figure 29). Measurements of the average concentration and HU were made
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using the GSI Viewer software with circular ROIs drawn within the cross-section of the inner
cylindrical volume (44-47 mm2) and the within the annular cross-section of the outer cylindrical
volume (19-23 mm2) (Figure 30). In addition, each concentric phantom was scanned in the
DXA scanner using the same methodology as described in Section 3.1.1.1, with rectangular
ROIs drawn on area corresponding to the inner and outer solution (Figure 31)

Table 19: Description of concentric phantoms constructed for concentric phantom experiments.
Each value is represented as a percent by volume concentration formatted as concentration of
K2HPO4 by volume/concentration of Optiray 320 by volume. The 0%/0% concentric phantom
contains only water in the inner and outer chambers. The 0%/0% and 10%/10% concentric
phantoms were shared between the two sets.

K2HPO4/
Optiray
320

5%/10%
0%/0%

K2HPO4/
Optiray
320

15%/10%

20%/10%

25%/10%

30%/10%

10%/15%

10%/20%

10%/25%

10%/30%

10%/10%
10%/5%
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Figure 28: Diagram describing the two sets of concentric phantoms constructed for Section
3.2.1. The color blue represents Optiray 320 solution and the color green represents K2HPO4
solution. The increasing concentration of the solute is represented by the darkening hue of
each color. The simplified diagrams on the far right illustrate for which solution the
concentration was increased and for which solution the concentration remained fixed in each
set.

Figure 29: Configuration of materials for concentric phantom DECT and SECT measurements
in air (left) and in scattering conditions (right).
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Figure 30: Example GSI Viewer in-air measurements of the K2HPO4 concentration in the inner
circular area and the Optiray 320 concentration in the annular area surrounding. The Optiray
320-water basis pair is used in this illustration.

Figure 31: Left: Placement of concentric phantoms for DXA scanning. Right: Rectangular ROIs
drawn on DXA image of concentric phantoms for the inner and outer chambers.
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For both the outer and inner solution, the measured concentration, HU, or aBMD was
plotted against the measurement made in the uniform syringe-phantom with the equivalent
concentration (but not the exact same solution). The data were fit with a linear regression and
the slope with 95% confidence intervals was compared with an expected value of either 1 or 0
with an f-test. Regressions with a y-intercept consistent with 0 within 95% confidence limits
were re-fit with a y intercept equal to 0. To produce error bars on the y-axis, an estimate of the
total variation L of the concentric measurements was assessed with the CV between images
o , phantom preparation M , and variation between scans p were taken from the uniform

syringe-phantom data and the noise a was taken from measurements made in the individual
concentric phantoms.
3.2.1.2. Results
3.2.1.2.1 DECT Concentric Phantom Accuracy
Most of the slopes measured did not vary significantly (p < 0.5) from their expected
value of unity or 0 (Table 20, Figures 33-34). The measured concentration of K2HPO4 in the
inner chamber, while a fixed concentration of Optiray 320 was present in the outer chamber,
was higher by ~13% in air than those measured for the uniform K2HPO4 phantom (Figure 32,
top). The measured concentration of Optiray 320 in the outer chamber, while a fixed
concentration of K2HPO4 was present in the inner chamber, was lower by ~12% than measured
in the uniform Optiray 320 phantom (Figure 33, top). Most notably, however, the K2HPO4
concentration increased in the phantoms in which the K2HPO4 concentration was fixed and the
Optiray 320 concentration increased (Figure 33, bottom) both in air and in scattering conditions.
The in-air measured concentration of K2HPO4 ranged from 276 mg/mL—399 mg/mL while the
expected concentration based on in-air measurement in the uniform 10% K2HPO4 syringephantom was just 258 ± 6 mg/mL.
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Figure 32: Material density image concentration measurements in air and scattering conditions
of concentric phantoms where the inner K2HPO4 solution concentration increases and the outer
Optiray 320 solution concentration is fixed. Error bars on the x-axis and y-axis indicate the total
variation of the uniform solution measurement and the measurement made in the concentric
phantom, respectively. Top Left: Measurements of K2HPO4 concentration. A slope of 1 is
expected for both measurements; in-air measurements yielded a slope of 1.13 ± 0.03 and
scatter measurements yielded a slope of 1.08 ± 0.08. Bottom Left: Measurements of Optiray
320 concentration. A slope of 0 is expected for both measurements; in-air and scatter
measurements both yielded a slope of -0.01 ± 0.04. Right: Graphic based on Figure 28
illustrating which solution concentration is changing, which solution concentration is fixed, and
which is being plotted to the left (arrow).
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Figure 33: Material density image concentration measurements in air and scattering conditions
of concentric phantoms where the inner K2HPO4 solution concentration is fixed and the outer
Optiray 320 solution concentration increases. Error bars on the x-axis and y-axis indicate the
total variation of the uniform solution measurement and the measurement made in the
concentric phantom, respectively. Top Left: Measurements of Optiray 320 concentration. A
slope of 1 is expected for both measurements; in-air measurements yielded a slope of 0.88 ±
0.03 and scatter measurements yielded a slope of 1.01 ± 0.04. Bottom Left: Measurements of
K2HPO4 concentration. A slope of 0 is expected for both measurements; in-air measurements
yielded a slope of 0.3 ± 0.1 and scatter measurements yielded a slope of 1.1 ± 0.4. Right:
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution
concentration is fixed, and which is being plotted to the left (arrow).
64

Table 20: Slope with 95% confidence intervals compared for a regression of the concentration
measured in the concentric phantom vs the concentration measured in the uniform syringephantom. Each concentric phantom was scanned both in air and in scattering conditions and
compared with the uniform syringe-phantom with both the equivalent concentration of K2HPO4
and Optiray 320 in those conditions. When the concentration of the material analyzed was
fixed, it was expected that the slope of the regression would be 0. When the concentration of
the material analyzed was changing, it was expected that the slope of the regression would be
unity. Slopes considered different from expectation are marked with a *.
Material
Analyzed
(mg/mL)
K2HPO4
(Air)
K2HPO4
(Scatter)
Optiray
(Air)
Optiray
(Scatter)
K2HPO4
(Air)
K2HPO4
(Scatter)
Optiray
(Air)
Optiray
(Scatter)

Fixed
Material

Changing
Material

Corresponding
Figure

K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)

Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)

Figure 33
(Bottom)
Figure 33
(Bottom)
Figure 33
(Top)
Figure 33
(Top)
Figure 32
(Top)
Figure 32
(Top)
Figure 32
(Bottom)
Figure 32
(Bottom)

Slope

Expected

0.3 ± 0.1*

0

1.1 ± 0.4*

0

0.88 ± 0.03*

1

1.01 ± 0.04

1

1.13 ± 0.03*

1

1.08 ± 0.08

1

-0.01 ± 0.04

0

-0.01 ± 0.04

0

3.2.1.2.2 SECT Concentric Phantom Correlation
The trends observed in material density image concentration measurements were
mostly also observed in single-energy HU measurements (Figures 35-36, Table 21). The
measured in-air CT number of K2HPO4 for a fixed concentration ranged from 390 HU to 547
HU at 120 kVp and from 535 HU to 772 HU where a value of 398 ± 8 HU and 533 ±11 HU was
expected respectively (Figure 35, bottom), based on measurements in uniform syringe65

phantoms. The lower than expected Optiray measurements in concentric phantoms in which
Optiray was changing was observed at 120 kVp but not at 80 kVp (Figure 35, top). The slightly
higher K2HPO4 concentration measurements in concentric phantoms where the Optiray
concentration was held fixed in air was not observed (Figure 34, top). Note that for the
concentric phantoms measured in air at 80 kVp in which the outer Optiray 320 concentration
was 25 or 30% (Figure 35, bottom), the HU reached the maximum value the software was
capable of reporting (3071 HU).
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Figure 34: SECT HU measurements of concentric phantoms in air and scattering conditions at
120 and 80 kVp where the inner K2HPO4 solution increases and the outer Optiray 320 solution
concentration is fixed. Error bars on the x-axis and y-axis indicate the total variation of the
uniform solution measurement and the measurement made in the concentric phantom,
respectively. Top Left: Measurements of K2HPO4 HU. A slope of 1 is expected for all
measurements; in-air measurements at 120 kVp yielded a slope of 0.99 ± 0.02 and scatter
measurements yielded a slope of 1.01 ± 0.03. In-air measurements at 80 kVp yielded a slope
of 1.02 ± 0.02 and scatter measurements yielded a slope of 1.03 ± 0.04. Bottom Left:
Measurements of Optiray HU. A slope of 0 is expected for all measurements; in-air and scatter
measurements at 120 kVp both yielded a slope of 0.0 ± 0.1. In-air measurements at 80 kVp
yielded a slope of 0.0 ± 0.1 and scatter measurements yielded a slope of 0.0± 0.2. Right:
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution
concentration is fixed, and which is being plotted to the left (arrow).
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Figure 35: SECT HU measurements of concentric phantoms in air and scattering conditions at
120 and 80 kVp where the inner K2HPO4 solution is fixed and the outer Optiray 320 solution
concentration increases. Error bars on the x-axis and y-axis indicate the total variation of the
uniform solution measurement and the measurement made in the concentric phantom,
respectively. Top Left: Measurements of Optiray HU. A slope of 1 is expected for all
measurements; in-air measurements at 120 kVp yielded a slope of 0.94 ± 0.5 and scatter
measurements yielded a slope of 0.93 ± 0.5. In-air measurements at 80 kVp yielded a slope of
0.97 ± 0.07 and scatter measurements yielded a slope of 0.97 ± 0.06. Note that for a 30%
Optiray 320 concentration, the CT number reached a maximum value at 80 kVp in air. Bottom
Left: Measurements of K2HPO4 HU. A slope of 0 is expected for all measurements; in-air
measurements at 120 kVp yielded a slope of 0.8 ± 0.3 and scatter measurements yielded a
slope of 0.9 ± 0.3. In-air measurements at 80 kVp yielded a slope of 0.09 ± 0.06 and scatter
measurements yielded a slope of 0.12 ± 0.04. Right: Graphic based on Figure 28 illustrating
which solution concentration is changing, which solution concentration is fixed, and which is
being plotted to the left (arrow).
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Table 21: Slope with 95% confidence intervals compared for a regression of the HU measured
in the concentric phantom vs the HU measured in the uniform syringe-phantom in air and in
scattering conditions at 120 and 80 kVp. Each concentric phantom was scanned both in air and
in scattering conditions and compared with the uniform syringe-phantom with both the
equivalent concentration of K2HPO4 and Optiray 320 in those conditions. When the
concentration of the material analyzed was fixed, it was expected that the slope of the
regression would be 0. When the concentration of the material analyzed was changing, it was
expected that the slope of the regression would be unity. Slopes considered different from
expectation are marked with a *.
Material Analyzed
(HU)
K2HPO4
(120 kVp) (Air)
K2HPO4
(120 kVp) (Scatter)
K2HPO4
(80 kVp) (Air)
K2HPO4
(80 kVp) (Scatter)
K2HPO4
(120 kVp) (Air)
K2HPO4
(120 kVp) (Scatter)
K2HPO4
(80 kVp) (Air)
K2HPO4
(80 kVp) (Scatter)
Optiray 320
(120 kVp) (Air)
Optiray 320
(120 kVp) (Scatter)
Optiray 320
(80 kVp) (Air)
Optiray 320
(80 kVp) (Scatter)
Optiray 320
(120 kVp) (Air)

Fixed
Material
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
K2HPO4
(Inner)

Changing
Material
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)
Optiray 320
(Outer)
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Figure
Figure 35
(Bottom)
Figure 35
(Bottom)
Figure 35
(Bottom)
Figure 35
(Bottom)
Figure 34
(Top)
Figure 34
(Top)
Figure 34
(Top)
Figure 34
(Top)
Figure 34
(Bottom)
Figure 34
(Bottom)
Figure 34
(Bottom)
Figure 34
(Bottom)
Figure 35
(Top)

Slope

Expected

0.08 ± 0.03*

0

0.09± 0.03*

0

0.09 ± 0.06*

0

0.12 ± 0.04*

0

0.99 ± 0.02

1

1.01 ± 0.03

1

1.02 ± 0.02

1

1.03 ± 0.04

1

0.0 ± 0.1

0

0.0 ± 0.1

0

0.0 ± 0.1

0

0.0 ± 0.2

0

0.94 ± 0.5*

1

Optiray 320
(120 kVp) (Scatter)
Optiray 320
(80 kVp) (Air)
Optiray 320
(80 kVp) (Scatter)

K2HPO4
(Inner)
K2HPO4
(Inner)
K2HPO4
(Inner)

Optiray 320
(Outer)
Optiray 320
(Outer)
Optiray 320
(Outer)

Figure 35
(Top)
Figure 35
(Top)
Figure 35
(Top)

0.93 ± 0.05*

1

0.97 ± 0.07

1

0.97 ± 0.06

1

3.2.1.2.3 DXA Concentric Phantom Correlations
DXA measurements of concentric phantoms are summarized in Figures 37-38. Similar
to the trend observed in DECT and SECT, aBMD measurements of K2HPO4 in the inner
chamber had a positive, nonzero slope (0.58 ± 0.03) despite a fixed concentration (Figure 37,
bottom, Table 22). This measurement also had a higher offset than expected by about 0.26
g/cm2. Measurements of Optiray 320 in the outer chamber, conversely, had a lower slope than
expected when the concentration was increased (Figure 37, top). This was also true of
measurements of K2HPO4 in the inner chamber while the concentration increased and the
concentration of the Optiray 320 in the outer chamber remained fixed (Figure 36, top). There
was also a large offset in this measurement, about 1.3 g/cm2 greater than the expected value
(0 g/cm2). The offset for outer chamber Optiray 320 measurements in this set of concentric
phantoms was less than the expected value by about 0.6 g/cm2 (Figure 36, bottom).
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Figure 36: DXA aBMD measurements of concentric phantoms where the inner K2HPO4 solution
increases and the outer Optiray 320 solution concentration is fixed. Error bars on the x-axis and
y-axis indicate the total variation of the uniform solution measurement and the measurement
made in the concentric phantom, respectively. Top Left: Measurements of K2HPO4 aBMD. A
slope of 1 and offset of 0 is expected; measurements yielded a slope of 0.4 ± 0.1 and an offset
of 1.3 ± 0.1. Bottom Left: Measurements of Optiray aBMD. A slope of 0 and offset of 2.58 ±
0.02 is expected; measurements yielded a slope of -0.1 ± 0.2 and an offset of 2.0 ± 0.2. Right:
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution
concentration is fixed and which is being plotted to the left (arrow).
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Figure 37: DXA aBMD measurements of concentric phantoms for which the inner K2HPO4
concentration is fixed and the outer Optiray 320 solution concentration increases. Error bars on
the x-axis and y-axis indicate the total variation of the uniform solution measurement and the
measurement made in the concentric phantom, respectively. Top left: Measurements of Optiray
aBMD. An offset of 0 and slope of 1 is expected; measurements yielded a slope of 0.8 ± 0.1
and an offset of -0.2 ± 0.5. Bottom left: Measurements of K2HPO4 aBMD. A slope of 0 and an
offset of 0.592 ± 0.009 is expected; measurements yielded a slope of 0.58 ± 0.03 and an offset
of 0.85 ± 0.01. Right: Graphic based on Figure 28 illustrating which solution concentration is
changing, which solution concentration is fixed and which is being plotted to the left (arrow).

72

Table 22: Slope and offsets with 95% confidence intervals compared for a regression of the
aBMD measured in the concentric phantom vs the aBMD measured in the uniform syringephantom. Each concentric phantom was scanned between eight 3/8 in. (9.5 mm) PMMA blocks
and compared with the uniform syringe-phantom with both the equivalent concentration of
K2HPO4 and Optiray 320 in those conditions. When the concentration of the material analyzed
was fixed, it was expected that the slope of the regression would be 0. When the concentration
of the material analyzed was changing, it was expected that the slope of the regression would
be unity. The expected offset is the measurement of the uniform syringe-phantom of equivalent
concentration to the material being analyzed ± the total variation in the uniform syringephantom measurement or 0 if the material being analyzed is changing in concentration. Slopes
and offsets considered different from expectation are marked with a *.

Measurement,
Phantom

Corresponding
Figure

K2HPO4 aBMD,
Optiray Changing
Optiray aBMD,
K2HPO4 Changing
Optiray aBMD,
Optiray Changing
K2HPO4 aBMD,
K2HPO4 Changing

Figure 37
(Bottom)
Figure 36
(Bottom)
Figure 37
(Top)
Figure 36
(Top)

Slope

Expected
Slope

Offset
(g/cm2)

Expected
Offset
(g/cm2)

0.58 ± 0.03*

0

0.85 ± 0.01*

0.592 ± 0.009

-0.1 ± 0.2

0

2.0 ± 0.2*

2.58 ± 0.02

0.8 ± 0.1

1

-0.2 ± 0.5

0

0.4 ± 0.1

1

1.3 ± 0.1*

0

3.2.1.3. Discussion
In theory, in three-dimensional images of two concentric cylinders each containing two
materials, the concentration of one material should not affect measurements made in another.
However, we measured and increasing value in the inner K2HPO4 solution with increasing
Optiray 320 concentration, despite a fixed composition. The effect appears in both DECT
(Figure 33, bottom) and SECT (Figure 35, bottom) indicating that, as in the scattering
conditions experiments in Section 3.1.2, the effect is likely caused by inaccuracies in the DECT
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material decomposition reconstruction from the single-energy data. Since every line integral
through this region contains the high attenuation (relative to K2HPO4) from the surrounding
Optiray 320, the effect may be attributed to limitations in the filtered back-projection used to
reconstruct the dual and single-energy CT images; that is, some attenuation from Optiray 320
may have “smeared” across the regions containing K2HPO4. The effect in this case is the
opposite from what might be expected in a beam hardening artifact, in which the measured
concentration or HU of the K2HPO4 solution might be expected to be lower than for a uniform
solution of the same concentration. Back-projection errors may also be responsible for the
deviation of the slope for the changing Optiray 320 concentration from 1 (Figure 33, Figure 35).
Higher variation in each measurement compared to in air may mask this effect in scattering
conditions in DECT.
It is not clear why in-air DECT concentration measurements of K2HPO4 are greater
(~13%) when surrounded by a fixed Optiray concentration than those measured in uniform
phantoms (Figure 32) as the corresponding effect is not present in single-energy data. As for
the Optiray measurements in increasing Optiray concentrations (Figure 33), the effect may be
masked in scattering conditions by the greater variation in each DECT measurement compared
to in air. It is unknown how the GSI Viewer software combines the data from each singleenergy beam. It is possible that while the greater than expected K2HPO4 measurements in a
changing K2HPO4 concentration are not discernable in single-energy data, there is an
cumulative effect when constructing dual-energy images. This cumulative effect may also
explain why the Optiray concentration measurements for a changing Optiray concentration in
air are lower than expected in DECT and at 120 kVp but not at 80 kVp.
The DXA measurements of the concentric phantoms demonstrate quantitative
inaccuracy stemming from signal integration. The concentration of the outer solute was
expected to contribute to the aBMD of the inner solute measured by DXA and lead to
inaccurate measurements. Consistent with expectations, although the inner K2HPO4 solution
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(meant to represent trabecular bone) concentration was held constant, the DXA aBMD
increased with higher Optiray 320 (meant to represent cortical bone) concentration present in
the outer chamber (Figure 37, bottom). The integration methodology also causes differences in
aBMD measurements due to different phantom geometries. DXA measurements of Optiray 320
aBMD with a changing concentration (Figure 37), even when made without integration through
a K2HPO4 solution, were less (~20%) than those made with in the uniform syringe-phantoms
with 95% confidence. This is due to differences in the thickness of the cylinders across the area
presented to the DXA beam and the different diameter of the concentric vs the uniform syringephantom cylinders (3.0 vs. 2.5 cm). When a DXA measurement is made off the axis of a
cylinder, the x-ray beam travels through a smaller thickness of the solution compared to a
measurement made along the axis of the same area, resulting in a smaller average aBMD. The
same is true for measurements of the same area made in the same location on two cylinders of
different diameter (Figure 38).

Figure 38: The aBMD varies for the same size and shaped ROI area on a cylinder depending
on position transverse to the axis and cylinder diameter.
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3.2.2. Reversed Concentric Phantoms
3.2.2.1. Materials and Methods
To further investigate the increasing K2HPO4 measurements for a fixed concentration
observed in DECT and SECT measurements in Section 3.2.1.2, three additional concentric
phantoms were constructed with the placement of the K2HPO4 and Optiray 320 solutions
reversed (Figure 39). The inner 5 mL vial was filled with an Optiray 320 dilution in water with a
concentration of 10, 20, or 30% by volume and the outer 50 mL centrifuge tube was filled with a
10% by volume solution of K2HPO4 in water for all three concentric phantoms. Dual and singleenergy CT scans were acquired and analyzed in the same manner as Section 3.2.1.1.

Figure 39: Diagram based on Figure 28 describing the set of three “reverse” concentric
phantoms constructed for the reversed concentric phantom experiment. The color blue
represents Optiray 320 solution, while the color green represents K2HPO4 solution. The
increasing concentration of the Optiray 320 represented by the darkening hue.The simplified
diagram on the far right illustrates for which solution the concentration was increased and for
which solution the concentration remained fixed, as in Figure 28.
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3.2.2.2. Results
The results for DECT are summarized in Figure 40 and SECT in Figure 41. To produce

error bars on the y-axis, an estimate of the total variation L of the concentric measurements

was assessed with the CV between images o , phantom preparation M , and variation between
scans p were taken from the uniform syringe-phantom data and the noise a was taken from

the measurement made in the individual reversed concentric phantoms. The Optiray solution
with a nominal concentration of 20% by volume appears to have been prepared incorrectly;
nonetheless, a general trend is apparent. In every plot the measured concentration and HU of
the Optiray 320 solution is increasing with concentration while the measured value of the
K2HPO4 solution remains relatively fixed.
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Figure 40: Left: Material density image concentration measurements in air (Top) and in
scattering conditions (Bottom) of the inner Optiray 320 solution of increasing concentration,
where the outer K2HPO4 solution concentration was fixed. Error bars on the x-axis and y-axis
indicate the total variation of the uniform solution measurement and the measurement made in
the concentric phantom, respectively. The point corresponding to 20% Optiray concentration
appears to reflect an improper Optiray solution preparation. Right: Graphic based on Figure 39
illustrating which solution concentration is changing, which solution concentration is fixed and
which is being plotted to the left (arrow).
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Figure 41: Left: SECT HU measurements in air (Top) and in scatter (Bottom) at 120 and 80 kVp
of the inner Optiray 320 solution of increasing concentration, where the outer K2HPO4 solution
concentration was fixed. Error bars on the x-axis and y-axis indicate the total variation of the
uniform solution measurement and the measurement made in the concentric phantom,
respectively. The points corresponding to 20% Optiray concentration appears to reflect an
improper Optiray solution preparation. Right: Graphic based on Figure 39 illustrating which
solution concentration is changing, which solution concentration is fixed and which is being
plotted to the left (arrow).
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3.2.2.3. Discussion
The increasing concentration and HU measurements of a fixed K2HPO4 solution with
increasing Optiray 320 concentration disappears when the relative position of the two solutions
in the concentric phantoms is reversed and the measurements are instead stable. This
indicates that the effect is geometrically dependent rather than an inherent property of the two
materials or the scanner. When the position of the Optiray 320 solution and the K2HPO4
solution were reversed in the concentric geometry, the effect probably disappeared because
many fewer line integrals containing K2HPO4 also contained Optiray 320. The Optiray 320
concentration increases as expected.
3.3. Subaim 3: Sensitivity of Measurement Methods
3.3.1. Materials and Methods
It is important for any measurement method used for BMD screening to be sensitive to
very small changes in bone density so that the screening is able to detect changes early
enough for preventative treatment. To compare the sensitivity of each measurement method, a
series of thirteen syringe-phantoms were prepared in 60 mL syringes containing 30 mL K2HPO4
solutions with concentrations by volume varying by 5/2x%, where x = 0 – 12. That is, percent
concentration successively varied as a half of the previous concentration, 5%, 2.5%, 1.25%,
etc. Because the excess volume from the K2HPO4 was too small to be evaluated from the
syringes, a quadratic regression was fitted to the table provided in Rao et al. (107) of water
concentration with increasing K2HPO4 concentration. An additional 30 mL syringe-phantom
containing pure distilled water (0% concentration) was prepared. Measurements of the K2HPO4
solutions were acquired on three separate dates with SECT and DECT in air and in scattering
conditions and with DXA as described in Sections 3.1.1.1 and 3.1.2.1 and the three
measurements were averaged.
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For this experiment, it was necessary to create a new estimate of total variation L for

each averaged measurement. Variation in phantom preparation, M , was assumed to be the

same value as calculated previously for K2HPO4. Variation between images, o , was estimated

from a stack of images obtained of a 2.5% K2HPO4 syringe-phantom in air and scattering

conditions using the method in section 3.1.1.1 and 3.1.2.1. Variation between scans, p , was

the standard deviation of the three-measurement mean. The noise, a , of each measurement
was taken as the average standard deviation of the mean for each concentration. The total
standard deviation L was obtained by summing the four variabilities in quadrature.

Two different tests assessing the sensitivity of each measurement method were

established. In the first test, the difference   Z ' r was considered, where Z is the

measurement of a given K2HPO4 concentration and r is the measurement for pure water. The

standard deviation of the difference  is defined by the propagation of error as I  st$  u$
where t and u are the total standard deviation L for the K2HPO4 syringe-phantom and the

water syringe-phantom respectively. The concentration of K2HPO4 for which  v 2I or

 v 2st$  u$ is defined as the discrete sensitivity of a given measurement method.

An additional non-discrete sensitivity test was sought to compare the measurement
methods within the range of K2HPO4 concentration equivalents expected to be measured using
SEQCT or DEQCT. In the second test, the K2HPO4 concentration, HU, and aBMD
measurements in air and scattering conditions from Sections 3.1.1.2 and 3.1.2.2 were
combined with the average concentration, HU, and aBMD measurements in this experiment,
plotted against the known K2HPO4 concentration, and fit with a new regression. Regressions
with a y-intercept consistent with 0 within the 95% confidence intervals were re-plotted with the
y-intercept set to 0. The smallest detectable change outside the 95% confidence interval in
K2HPO4 concentration equivalent from those associated with the normal value of a post81

menopausal woman (57,112) was determined for DECT and SECT in air and in scattering
conditions and for DXA and this smallest detectable change was defined as the sensitivity.
Concentrations of K2HPO4 determined to be indistinguishable from water with 95% confidence
with a measurement method in the first sensitivity analysis were excluded from this analysis for
that measurement method.
3.3.2. Results
3.3.2.1. DECT Sensitivity
The measured concentration of K2HPO4 solution with DECT as a function of the
concentration (from phantom preparation) used to estimate the sensitivity in the first test is
plotted in Figure 42. The smallest detectable K2HPO4 concentration from this experiment was
0.16% by volume in air and 2.5% in scattering conditions. The extended K2HPO4 concentration
plot from the second sensitivity test is shown in Figure 43. The equation for the in-air
regression with 95% confidence is  1.08

0.02& mg/mL . The normal vBMD of

postmenopausal women as assessed with QCT is approximately 126 mg/mL K2HPO4 (112),
which would according to the fit correspond to a measured concentration of 1.08126 

136 mg/mL. The lower 95% confidence limit on a measurement of 136 mg/mL is 1.06 !

126 mg/mL  134 mg/mL or 134/1.08  124 mg/mL true K2HPO4 concentration. The
minimum difference in true K2HPO4 concentration from normal that can be detected with 95%

confidence is therefore 126 mg/mL ' 124 mg/mL  2 mg/mL or 2 mg/mL ÷ 126 mg/mL= 2%.
Likewise, the equation for the regression in scatter is

 0.73

0.01& mg/mL, so a decrease

in normal bone mineral in excess of 2 mg/mL true K2HPO4 concentration (2%) is necessary
before detection.
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Figure 42: Material density image concentration measured in air and in scattering conditions for
a series of K2HPO4 syringe-phantoms for which the concentration of the solute decreases

logarithmically. The error bars represent 2I for that measurement, where  is the difference
between the measurement for that K2HPO4 concentration and water. The error bars are too
small to be visible for most points in air. The smallest K2HPO4 concentration distinguishable
from water in air was 0.16% and 2.5% in scatter.
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Figure 43: Extended plot of K2HPO4 concentration for the purpose of evaluating DECT
sensitivity. Error bars on the y-axis indicate total variation for each measurement. The dotted
lines indicate the 95% confidence intervals. The equation of the regression in air with 95%
confidence is

 1.08

0.02& xc yz/y{. The equation of the regression in scattering

conditions with 95% confidence is

 0.73

0.01& xc yz/y{.

3.3.2.2. SECT Sensitivity
The measured concentration of K2HPO4 solution with SECT as a function of the
concentration (from phantom preparation) used to estimate the sensitivity in the first test is
plotted in Figure 44. The smallest detectable K2HPO4 concentration from this experiment was
0.16% by volume in air and 2.5% in scattering conditions. The 120 and 80 kVp scatter
regression from the extended K2HPO4 concentration plot in the second sensitivity test (Figure
45) was found to have an offset consistent with zero, so the offset was set to 0 and the slope
recalculated with this constraint (shown). The equation for the 120 kVp regression with 95%
confidence is

 1.54

0.04 HU mg/mL &  19

11  HU in air and

 1.12

0.02 HU mg/mL & in scattering conditions. The equation for the 80 kVp regression with
95% confidence is

 2.09

0.05 HU mg/mL &  21
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14 HU in air and



1.48

0.03 HU mg/mL & in scattering conditions. According to the regression for a 120

kVp HU measurement in air, the normal vBMD of 126 mg/mL K2HPO4 corresponds to a HU of

1.54 HU mg/mL 126 mg/mL  19 HU  213 HU. The lower 95% confidence limit on a

measurement of 213 HU is 1.50 HU mg/mL ! 126 mg/mL  8 HU  197 HU or 197 HU '
19 HU/1.54HU mg/mL   116 mg/mL K2HPO4. The minimum difference in K2HPO4

concentration from normal that can be detected with 95% confidence is therefore 126 mg/mL '

116 mg/mL  10 mg/mL or 10 mg/mL ÷ 126 mg/mL = 8%. Using similar calculations, it was
determined that a change of 2 mg/mL (2%) could be detected at 120 kVp in scattering

conditions, a change of 10 mg/mL (8%) at 80 kVp in air and in scattering conditions a change
of 3 mg/mL (2%).

Figure 44: SECT HU measured in air and in scattering conditions at 120 and 80 kVp for a
series of K2HPO4 syringe-phantoms for which the concentration of the solute decreases

logarithmically. The error bars represent 2I for that measurement, where  is the difference
between the measurement for that K2HPO4 concentration and water. The error bars are too
small to be visible for most points in air. The smallest K2HPO4 concentration distinguishable
from water in air was 0.16% and 2.5% in scatter for both 120 and 80 kVp.
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Figure 45: Extended plot of K2HPO4 concentration for the purpose of evaluating SECT
sensitivity. Error bars on the y-axis indicate total variation for each measurement; some are too
small to be visible. The dotted lines indicate the 95% confidence intervals. The equation for the
120 kVp regression with 95% confidence is
in air and

 1.12

 1.48

0.04 CD yz/y{ &  19

11  CD

0.02 CD yz/y{ & in scattering conditions. The equation for the 80

kVp regression with 95% confidence is
and

 1.54

 2.09

0.05 CD yz/y{ &  21

0.03 CD yz/y{ & in scattering conditions.

14 CD in air

3.3.2.3. DXA Sensitivity
The measured concentration of K2HPO4 solution with DXA as a function of the
concentration (from phantom preparation) used to estimate the sensitivity in the first test is
plotted in Figure 46. The smallest detectable K2HPO4 concentration from this experiment was
0.63 % by volume. The extended K2HPO4 aBMD plot from the second sensitivity test is shown
in Figure 47. The equation for the regression with 95% confidence is
10" g/cm$ mg/ml & ' 8

 2.23

0.03 !

1 ! 10$  g/cm$ . The normal aBMD of postmenopausal

women as assessed with DXA is approximately 0.99 g/cm2 (57). According to the regression,

this corresponds to a K2HPO4 concentration of &  0.99 g/cm$  0.08 g/cm$ /2.23 ! 10"  
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480 mg/mL. The lower 95% confidence interval of 480 mg/mL is 2.20 ! 10" ! 480 g/cm$ '

9 ! 10$ g/cm$   0.97 g/cm$ or 0.97  0.08g/cm$ /2.23 ! 10" g/cm$ mg/ml  

470 mg/mL K2HPO4 concentration. The minimum difference in true K2HPO4 concentration from

normal that can be detected with 95% confidence is therefore 480 mg/mL ' 470 mg/mL 
10 mg/mL or 10 mg/mL ÷ 480 mg/mL = 2%.

Figure 46: DXA aBMD measured for a series of K2HPO4 syringe-phantoms for which the
concentration of the solute decreases logarithmically. The error bars represent 2I for that

measurement, where  is the difference between the measurement for that K2HPO4

concentration and water. The smallest K2HPO4 concentration distinguishable from water was
0.31%.
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Figure 47: Extended plot of K2HPO4 concentration for the purpose of evaluating DXA
sensitivity. Error bars on the y-axis indicate total variation for each measurement; most are too
small to be visible. The dotted lines indicate the 95% confidence intervals. The equation for the
regression with 95% confidence is

10'2 z/|y2.

 2.23

0.03 ! 10" z/|y$ yz/y} & ' 8

1!

Extended K2HPO4 Measurements (DXA)

Measured aBMD

1.5

1.0

0.5

0.0
0

200

400

600

800

Known K2HPO4 Concentration (mg/mL)

The smallest concentration of K2HPO4 distinguishable from water in this experiment by
each measurement method is summarized in Table 23 along with the magnitude of the different
sources of variation for the measurement method at that concentration. Both the 120 kVp and
80 kVp SECT scans were found to detect the smallest concentration of K2HPO4, with DECT in
air slightly less sensitive, but both DECT and SECT in scattering conditions were found to be
roughly half as sensitive as DXA in distinguishing K2HPO4 from water in this experiment.
The smallest detectable change in concentration of K2HPO4 from normal in this
experiment by each measurement method is summarized in Table 24. DECT in air and scatter
was found to be more sensitive than DXA, although only slightly more sensitive than SECT in
scattering conditions at 80 and 120 kVp with the techniques used. DXA and SECT at 120 and
80 kVp are equally sensitive in this experiment in terms of the magnitude of K2HPO4
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concentration detectable, although for DXA measurements this represent a smaller percentage
change from normal.

Table 23: The minimum discrete amount of K2HPO4 by volume percentage and concentration
that can be distinguished from water by each measurement method in air and in scattering
conditions when applicable. The magnitude of each source of variation for that measurement
method in the measurement of the listed concentration is also shown for comparison.

Measurement
Method
SECT
(120 kVp Air)
SECT
(80 kVp Air)
DECT
(Air)
DXA
SECT
(120 kVp
Scatter)
SECT
(80 kVp
Scatter)
DECT
(Scatter)

% K2HPO4
Solution

K2HPO4
Concentration
(mg/mL)

σp

0.16%

3.8

0.2 HU

0.16%

3.8

0.2 HU

0.16%

7.6

0.31%

7.6

2.5%

61

2 HU

2.5%

61

2.5%

61

σr

σn

σt

0.1 HU

2 HU

2 HU

0.4 HU

2 HU

2 HU

0.4
mg/mL
0.004
g/cm2

1.3
mg/mL

1.4
mg/mL
0.005
g/cm2

2 HU

1 HU

17 HU

17 HU

3 HU

2 HU

1 HU

26 HU

26 HU

2 HU

2 HU

2 HU

12 HU

13 HU

-0.09
mg/mL
0.004
g/cm2

89

σi
0.2
HU
0.1
HU
-0.05
mg/mL
-

-

Table 24: The smallest detectable reduction in K2HPO4 concentration from normal at the 95%
confidence interval of the regression as a concentration and percentage of the normal value.
The normal K2HPO4 concentration equivalent vBMD for post-menopausal women is estimated
at 126 mg/mL.
Measurement Method

K2HPO4 Concentration (mg/mL) Percentage

DECT (Air)
DECT (Scatter)
SECT (120 kVp Scatter)
SECT (80 kVp Scatter)
DXA
SECT (120 kVp Air)
SECT (80 kVp Air)

2
2
3
3
10
10
10

2%
2%
2%
2%
3%
8%
8%

3.3.3. Discussion
The two different experiments for each measurement method gave two different
perspectives on its sensitivity. The experiment in which differentiation of K2HPO4 from water
was the goal highlighted the significant effect of scatter on the variation of SECT and DECT,
and it is clear from Table 23 that the increase in total variation L in these measurement
methods in scattering conditions, driven by increases in noise, is responsible.
A better understanding of the sensitivity expected in clinical measurements is given by
the second experiment, in which the slope of the regression and the uncertainty of the
regression parameters determines the modality’s sensitivity. DECT was able to detect a smaller
change in normal bone K2HPO4 concentration in air and in scattering conditions relative to
DXA, indicating greater sensitivity (Table 24). Previous research (112) has shown that normal
and osteoporotic bone densities for post-menopausal women correspond to K2HPO4
concentrations of approximately 126 ± 24 and 79 ± 24 mg/mL, respectively. The smallest
detectable change of ~2-3 mg/mL with DECT in air and both DECT and SECT in scattering
conditions is well within the standard deviation of the mean value for each population (24
mg/mL). The smallest detectable change of ~10 mg/mL DXA and SECT in scatter found is
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likewise sufficient for distinguishing osteoporotic patients from non-osteoporotic patients. Based
on our results, in theory a DECT or SECT measurement could detect a change in BMD before
DXA.
The rankings of the measurement methods by sensitivity are different for the two
experiments. The results from the second experiment indicating DECT measurements in air
and both DECT and SECT measurements in scattering conditions are more sensitive than DXA
(Table 24) are likely due to the fact that two different equivalent concentrations K2HPO4 are
being used as the reference. The K2HPO4 concentration equivalent of trabecular BMD
assessed by SEQCT is much less than the K2HPO4 concentration equivalent of the integrated
trabecular and cortical BMD that is assessed by DXA. This result then highlights a theoretical
advantage of DECT and SECT. The ability to measure BMD specifically for trabecular bone as
possible with DECT may further increase its relevance and sensitivity over DXA for detecting a
change in normal BMD for postmenopausal women. However, DECT sensitivity may be
impacted by the changes in slope from uniform geometry seen in some concentric phantom
concentration measurements (Section 3.2.1.2.1).
It is important to remember that both sensitivity and variation determine the usefulness
of a measurement method in screening for small changes in BMD. Scatter is present in clinical
measurement; therefore, despite the results indicated in Tables 23 and 24, the much reduced
total variation of DXA compared to SECT measurements in scattering conditions (0.2% vs 1%)
(Table 18) as well as the reduced dose and cost may more than compensate for the very slight
reduction in sensitivity and make DXA the preferred modality. It is also important to note that
there was no attempt to match the dose of the DECT and SECT techniques, so it is possible
that the theoretical sensitivity of SECT could be even greater than that found in these results.
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3.4. Subaim 4: Correlation of Base Pairs
3.4.1. Materials and Methods
In order to directly compare the performance of DECT concentration with DXA aBMD, a
single basis pair for which to evaluate all phantoms is desirable. To assess the correlation
between different DECT material decomposition basis pairs, the measurement of the
concentration of the solute in the Optiray 320, K2HPO4, and 10 gm% K2HPO4 solution uniform
syringe-phantoms was made using each of the following basis pairs: Optiray 320-water,
K2HPO4-water and 10 gm% K2HPO4 solution-ethanol. Identical ROIs were drawn on the
constituent basis pair images for each additional basis pair. The concentration of each solute in
each basis pair image was plotted against the concentration of the solute measured with the
constituent basis pair. The data were fit with a linear regression and their correlations
evaluated.
3.4.2. Results
The correlation between the GSI-derived concentration of the constituent solute and the
concentration of each other solute was perfectly correlated (R2=1) for each set of syringephantoms except for the measured Optiray 320 concentration of the 10 gm% K2HPO4 solution
syringe-phantoms, which was very highly correlated (R2 > 0.995). The results are summarized
in Figures 49-51 and Table 25. It is interesting to note the very high concentrations of 10 gm%
K2HPO4 solution measured using the of 10 gm% K2HPO4 solution-ethanol basis pair for each
set of syringe-phantoms relative to the measured concentration of K2HPO4. This is because the
concentration of two different solutes is being assessed (pure K2HPO4 vs. a solution of K2HPO4
in water).
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Figure 48: The solute concentrations with different material decomposition basis pairs are
measured in the syringe-phantom set containing Optiray 320 and water and plotted against the
derived Optiray 320 concentration using the Optiray 320-water basis pair.

Figure 49: The solute concentrations with different material decomposition basis pairs are
measured in the syringe-phantom set containing K2HPO4 and water and plotted against the
derived K2HPO4 concentration using the K2HPO4 -water basis pair.
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Figure 50: The solute concentrations with different material decomposition basis pairs are
measured in the syringe-phantom set containing 10 gm% K2HPO4 solution and ethanol and
plotted against the derived concentration of 10 gm% K2HPO4 solution using the 10 gm%
K2HPO4 solution -ethanol basis pair.

Table 25: The squared Pearson’s correlation coefficient for each linear regression of the
derived concentration using a given basis pair against the constituent basis pair for that series
of syringe-phantoms.

Base Pair Correlation (R2)
Optiray 320
K2HPO4
10 gm% K2HPO4 Solution

Optiray 320
(Derived)
1.000
1.000
0.996

K2HPO4
(Derived)
1.000
1.000
1.000

10 gm% K2HPO4 Solution
(Derived)
1.000
1.000
1.000

3.4.3. Discussion
The nearly perfect agreement between all basis pairs is an expected result based on
the known principles of material decomposition (113). The lack of perfect agreement for the
Optiray 320 basis pair decomposition of the 10 gm% K2HPO4 solution syringe-phantoms was
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very likely due to the low concentrations of Optiray 320 measured and the subsequent lack of
significant figures. With more significant figures the regression would expected to be perfect as
well. However, the perfect agreement found in this experiment may depend on the mass
attenuation coefficient of the two materials in each basis pair being sufficiently different at the
effective energies used in DECT. The ethanol-water basis pair is not expected to produce
similar results due to difficulties in the material decomposition process, possibly related to the
similar mass attenuation coefficients of the two basis material in the range of rsDECT x-ray
energies (Section 3.1.1.3) . The advantage of perfect correlation between different basis pairs
is the ability to translate density estimates between different materials, as investigated in the
next section.

4. Specific Aim II: Relating DECT to DXA
4.1. Subaim 1: Correlation of DECT and DXA
4.1.1. Materials and Methods
To directly compare the performance of DECT and DXA, it is useful to establish if there
is a relationship between measurements made by the two methods. To investigate a possible
predictable relationship between material density image concentration measurements acquired
from DECT and aBMD acquired from DXA, K2HPO4 concentrations with the K2HPO4-water
basis pair were measured in air for each of the Optiray 320, K2HPO4, and 10 gm% K2HPO4
solution uniform syringe-phantoms and plotted with the corresponding DXA aBMD
measurements on the ordinate. Here the perfectly linear relationship between each basis pair
established in Section 3.4.2 was exploited to combine the measurements of each syringephantom on to a single plot using the same basis pair (K2HPO4-water). The data were fit with a
linear regression and the degree of correlation was assessed with the Pearson’s correlation
coefficient.
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4.1.2. Results
The correlation between DXA aBMD and K2HPO4 concentration for the uniform twomaterial syringe-phantoms is summarized in Figure 51. The two measurements were highly
correlated (R2 > 0.992).

Figure 51: Correlation of K2HPO4 concentration measured from material density images using
the K2HPO4-water basis pair for three different solutes with aBMD measured with DXA.
4.1.3. Discussion
Figure 51 is very interesting because it suggests that concentration measurements
acquired with DECT in air are linearly correlated with DXA aBMD measurements, despite the
two measurement methods assessing composition using two very different methodologies. Due
to the perfectly linear relationship between different material density image basis pairs, a
similar linear regression with the exact same Pearson’s correlation coefficient could be found
for DXA aBMD and nearly any other material, provided there was sufficient difference between
the mass attenuation coefficients of the two material bases in the appropriate energy range.
While the relationship is geometrically dependent due to the DXA’s areal density
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measurements, a linear relationship between the two modalities suggests that it may indeed be
possible to relate a DECT measurement to an aBMD measurement of a given sample.
4.2. Subaim 2: DECT Integration and DXA Comparison
4.2.1. Materials and Methods
To evaluate the ability of material density image concentration measurement to predict
DXA aBMD, 34 DECT, SECT, and DXA image sets were obtained, consisting of three uniform
syringe-phantoms of each solute composition (Optiray 320, K2HPO4, 10 gm% K2HPO4 solution)
plus one 2.5% K2HPO4 syringe-phantom, three phantoms from each set of concentric
phantoms, including the shared (10% inner K2HPO4/10% outer Optiray 320) phantom, the QC
phantom included with the Hologic Discovery DXA scanner (Figure 52), the European Spine
Phantom (Figure 53), and nine animal bones as unknown, arbitrary anthropomorphic samples.
The European Spine Phantom (114) (Quality Assurance and Radiology in Medicine,
Möhrendorf, Germany) is a tool designed to relate CT and DXA measurements consisting of
three lumbar spine inserts designed to provide a clinical range of three different bone mineral
(HA) densities. The animal bones were of bovine or porcine origin obtained in a raw condition
from a grocery store (neck bones) or in cured form from a pet clinic (all others). They included a
shank, a collection of five neck bones, a femoral head, and a set of two vertebral bodies
(Figure 54).
The image sets were obtained from the DECT scanner using the GSI-6 DECT protocol
(Table 11) with 5 mm images and at 80 kVp/200 mA with a 1s tube rotation time and medium
body filter selected. 80 kVp was selected instead of 120 due to the increased sensitivity to
material composition. 2.5 mm images for the femoral head and one positioning of the vertebral
bodies were obtained at 80 kVp.
The animal bones were also scanned in the DXA scanner between PMMA blocks as
used for the liquid solution phantoms (Figure 55). The vertebral bodies were oriented in two
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different positions in the DECT and DXA scanners, in order to present different areas for aBMD
measurements. Instead of manual ROIs, the DXA software automatically identified bone
material and corresponding ROIs for which the aBMD was determined for the QC phantom,
animal bones, and ESP. Because the DXA aBM
aBMD
D measurements of the QC phantom and ESP
relied on user delineation of the individual vertebral bodies, three scans were acquired and the
measurements were averaged.

Figure 52: Left: Anthropomorphic QC phantom included with the Hologic Discovery DXA
scanner. The cuboid phantom is designed to produce a measured aBMD of about 1 g/cm2 on
the scanner. Center: DECT K2HPO4 material density map. Right: SECT 80 kVp HU image.
image

Figure 53: Left: The European Spine Phantom
Phantom. Center: DECT K2HPO4 material density map.
Right: SECT 80 kVp HU image.
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Figure 54: Top to bottom: Shank, femoral head, vertebral bodies placed parallel to scan axis,
vertebral bodies placed perpendicular to scan axis, neck bones. Left to right: photograph,
DECT K2HPO4 material density map, SECT 80 kVp HU image.
99

Figure 55: Arrangement of materials for measurement of animal bones with the DXA scanner.

A methodology for processing and analyzing DECT and SECT data to produce an areal
BMD in g/cm2 was devised to fully evaluate the relationship between DXA aBMD and material
density image concentration measurements, as well as SECT HU measurements for
comparison. To assist the comparison, the European Spine Phantom was scanned using the
GSI-6 protocol (Table 11). The DECT and SECT scans of the European Spine Phantom were
used to convert the raw K2HPO4 density and 80 kVp HU of each of the phantom’s three
vertebral bodies to the true HA density provided by the manufacturer using a linear
transformation function estimated by fitting the data (Figure 56).
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Figure 56: Linear regression used to convert material density image-derived K2HPO4
concentration (left) and 80 kVp HU (right) to HA concentration using HA density provided by
QRM. The equation of the line for DECT K2HPO4 measurements is y = 0.8445x - 3.536 (in
(mg/mL)/(mg/mL)). The equation of the line for SECT 80 kVp HU measurements is y = 0.5125x
(in (mg/mL)/HU) - 6.800 (in mg/mL).

A diagram of the CT image integration process is illustrated in Figure 57. Axial image
stacks of the DECT material density map with the K2HPO4-water basis pair and the SECT HU
map transformed into HA density were re-binned, avoiding interpolation, into coronal-plane
images using ImageJ image analysis software (115). A threshold for “bone material” in the
stack was visually determined and voxels below the threshold in each image were set to 0
mg/mL. The images in each stack were arithmetically summed into a single image, on which a
new threshold was applied to segment the “bone” or a manual ROI corresponding to the DXA
ROI was placed. A measurement of the integrated density ~, or the sum of the value of each

selected pixel in mg/mL HA, and the total area ] of the selected pixels in mm2 was calculated

for each summed image after segmentation. The estimate of aBMD in HA density, expressed in
g/cm2 based on DECT and SECT data was then calculated as follows:


Z+* k   Q~ !

111i 
T / Q]


!
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Equation 4.2.1-1

where ~ is the integrated density in units of mg/cm3 HA,

is the voxel volume in mL3, and ] is

the total area of the selected pixels on the integrated DECT or SECT image.

Figure 57: Simplified schematic diagram of the DECT or SECT image integration process for
the ESP. A) An axial image set is re-binned into coronal images. A threshold is applied and the
remaining voxels are set to zero B) The thresholded images are then integrated into a single
image. C) A new threshold is applied and D) the resulting area (within an ROI in this case) is
recorded along with the integrated density from which to calculate the aBMD (right).
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The integration processing described was applied to the 34 DECT image sets. The 80
kVp SECT images were processed in the same manner for comparison with a similar HA
conversion (Figure 56) applied, excluding three phantoms in which a large number of pixels
attained the maximum CT number (25% Optiray 320 uniform syringe-phantom, 10%/30%
concentric phantom, and shank). The HA aBMD (g/cm2) for DECT and SECT were plotted with
DXA aBMD measurements on the ordinate and the data were fit with a linear regression.
Correlation was assessed using Pearson’s correlation coefficient and a slope and offset
calculated with 95% confidence. The DECT and SECT HA aBMD were compared with DXA
aBMD with Bland-Altman analysis.
4.2.2. Results
4.2.2.1. DECT Integration
The measurements of aBMD between the two modalities were found to be correlated
(R2 = 0.983, p < 0.0001), and the regression (Figure 58) is y = (0.95 ± 0.04)x (in (g/cm2)/
(g/cm2)) + (0.28 ± 0.09) (in g/cm2). The range of DXA aBMD values expected to be seen in
clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2,(53) is shown in more detail in
Figure 59. The Bland-Altman analysis, (Figure 60, Table 26) yielded a mean difference of 0.205
g/cm2 with a standard error of 0.005 g/cm2, indicating a consistent underestimation of DXA
aBMD by DECT aBMD. The 95% confidence interval for the limits of agreement between DXA
and material density image-derived aBMD were calculated to be -0.16—0.57 g/cm2. In the
clinical range, Bland-Altman analysis yielded a mean difference of 0.27 g/cm2 with a standard
error of 0.01 g/cm2, and a 95% confidence interval for the limits of agreement of -0.05—0.60
g/cm2.
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Figure 58: Correlation of integrated HA aBMD acquired from DECT images and DXA aBMD.
The linear regression is plotted with 95% confidence intervals (dotted lines) and the line of
equivalence. The equation of the regression is y = (0.95 ± 0.04)x (in (g/cm2)/(g/cm2)) + (0.28 ±
0.09) (in g/cm2).
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Figure 59: Enlargement of Figure 58 showing the range of DXA aBMD values expected to be
seen in clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2. Dotted lines
represent the 95% confidence intervals and the line of equivalence is shown for reference.
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Figure 60: Bland-Altman analysis comparing DECT aBMD and DXA aBMD of a variety of
phantoms illustrated in Figure 58. The mean difference was 0.205 g/cm2 with a standard error
of 0.005 g/cm2.

Table 26: Bland-Altman statistics of comparison between DECT HA aBMD and DXA aBMD.
Bias
(g/cm2)
0.21

Standard Deviation of
Bias (g/cm2)
0.18

Upper Limit of
Agreement (95%)
0.57

Lower Limit of
Agreement (95%)
-0.16

4.2.2.2. SECT Integration
The correlation for SECT integration measurements is nearly as high (R2 = 0.968) as for DECT
(Figures 62-63). The regression was found to have a y-intercept consistent with 0 within the
95% confidence intervals (0.05 ± 0.1) and so was re-plotted with the y-intercept set to 0. The
regression, with 95% confidence intervals, is y = (1.25 ± 0.5)x (in (g/cm2)/ (g/cm2)). The BlandAltman analysis (Figure 63, Table 27) yielded a mean difference of -0.276 g/cm2 with a
standard error of 0.008 g/cm2, indicating a consistent underestimation of DXA aBMD by SECT
aBMD. The 95% confidence interval for the limits of agreement between DXA and SECT106

derived aBMD were calculated to be -0.17—0.72 g/cm2. In the clinical range, Bland-Altman
analysis yielded a mean difference of 0.24 g/cm2 with a standard error of 0.01 g/cm2, and a

DXA aBMD (g/cm2)

95% confidence interval for the limits of agreement of -0.10—0.58 g/cm2.

Figure 61: Correlation of integrated 80 kVp HU areal density acquired from SECT images and
DXA aBMD. The linear regression is plotted with 95% confidence intervals, represented as
dotted lines. The equation of the regression is y = (1.25 ± 0.5)x (in (g/cm2)/(g/cm2)). The line of
equivalence is shown for comparison.
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Figure 62: Enlargement of Figure 61 showing the range of DXA aBMD values expected to be
seen in clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2. Dotted lines
represent the 95% confidence intervals of the regression. The line of equivalence is shown for
comparison.

Figure 63: Bland-Altman analysis comparing SECT aBMD and DXA aBMD of a variety of
phantoms illustrated in Figure 61. The mean difference was -0.276 g/cm2 with a standard error
of 0.008 g/cm2.
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Table 27: Bland-Altman statistics of comparison between SECT HA aBMD and DXA aBMD.
Bias
(g/cm2)
0.21

Standard Deviation of
Bias (g/cm2)
0.21

Upper Limit of
Agreement (95%)
0.14

Lower Limit of
Agreement (95%)
-0.70

4.2.3. Discussion
We have taken a three-dimensional imaging modality and created a two-dimensional
image for the purpose of comparing its performance to a two-dimensional modality. aBMD
measurements in g/cm2 from DECT integration are well-correlated with aBMD in g/cm2
measured with DXA. The slope (near unity, 0.95 ± 0.04) of the linear regression to the DECT
HA areal density plot lends credibility to the DECT integration methodology and suggests the
two measurement methods are indeed assessing the same fundamental quantity, the total
volumetric density of bone mineral. However, the 95% upper and lower limits of agreement of
the DXA aBMD (-0.16-0.57 g/cm2) are of the same magnitude as a change in DXA aBMD from
normal to osteoporotic (about 0.3 g/cm2) (53), limiting the utility of a conversion between the
two measurements.
SECT integration measurements are also very well-correlated (R2 = 0.968) with DXA
aBMD. However, the trend of SECT integration measurements is an increasing distance from
the line of equivalence with increasing SECT aBMD (Figure 62). The limits of agreement for
SECT aBMD measurements with DXA aBMD measurements are not an improvement over
those for DECT (Table 27).
The aBMDs from DECT and SECT in this experiment were both calculated from images
acquired in air. Based on results obtained in Sections 3.1. and 3.2, the effect of surrounding
tissue may further complicate the observed linear relationship of each with DXA aBMD in
clinical imaging. There is some uncertainty introduced in the manual identification of bone
material and the re-binning process used. Additionally, the reconstruction does not exactly
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match the fan-beam reconstruction used in DXA imaging. Finally, the difference in the
calculation and application of the pixel-by-pixel HA density in the dual-energy processing of
DECT and DXA (DECT used a correction based on known HA densities, while DXA used an
empirical correction based on the “soft tissue” composition) may have affected our results. All
of these factors should be considered in any future applications of this method.

5. Conclusion
We have shown that the rsDECT measurements of material concentration obtained with
material density images have an RMS accuracy error greater than 5% in air. Accuracy is further
reduced under scattering (clinical) conditions (~8-27%), and to a lesser extent with different
GSI protocols and patient positioning (< 5%). The accuracy of material density image
concentration measurements is also impacted by the attenuation geometry of bone, where a
lower-attenuating material of interest is surrounded by a more highly attenuating material. The
denser the higher-attenuating material, the higher the measured concentration of the inner
material tends to be. These effects, (excepting the effects of DECT protocol), are all observed
in SECT data well, suggesting that the dual-energy reconstruction algorithm is not fully
compensating for effects inherent in the single-energy data used in the reconstruction. It is
important to emphasize that the processing of the dual-energy images in the material density
images is only theoretically understood; the details of the implementation, including the
reconstructions of the integrated signals (e.g. if it is a linear or higher order function
(9,113,116)) and ways in which single-energy inaccuracies could perpetuate to dual-energy
data, is unknown.
Based on our assessment of sensitivity, DECT measurements in scattering conditions are
marginally more sensitive than DXA to a change in BMD from normal for postmenopausal
women (~1 mg/mL K2HPO4) based on the 95% confidence limits of a regression fitted to
K2HPO4 syringe-phantom measurements. While this is a promising result, the advantage of the
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minor increase in sensitivity is undercut by the inaccuracies in the absolute concentration
measurements as well as higher dose (in this study, the CTDIvol of DECT with GSI-6 protocol
was 33.43 mGy, compared with 12.46 mGy and 5.59 mGy at 120 and 80 kVp, respectively, and
0.020 mGy max for the DXA exam). Because Bland-Altman analysis demonstrates that DECT
aBMD integration is not sufficiently accurate to reliably produce a DXA aBMD (measurements
are expected to differ from DXA aBMD by anywhere from -0.16-0.57 g/cm2 compared to a
change in aBMD of about 0.3 g/cm2 expected between normal and osteoporotic bone) and is
also comparable to SECT aBMD integration (-0.72-0.17 g/cm2), the overall advantage of DECT
over SECT for assessing BMD based on this study is not clear. DECT material density images
would require detailed corrections to produce concentration measurements with clinically
acceptable accuracy.

6. Future Work
Our study was limited to comparing a single DECT vendor and implementation to a single
DXA device. Although we were able to partially evaluate the rsDECT technique in the HD750
scanner, the performance of an alternative commercial DECT implementation such as dualsource DECT in characterizing BMD is unknown. While in our study the Hologic Discovery is
assumed to have comparable performance to other currently used DXA scanners, the rsDECT
has not yet been compared to any other device.
Only a few material basis pairs were assessed for accuracy, at least one of which, ethanolwater, being inappropriate for general use. There could be many other material basis pairs as
problematic as ethanol-water. A wider range of materials evaluated with GSI dual-energy
imaging could provide a more comprehensive picture of the technology, particularly clinically
relevant materials such as iron (Fe).
While the effect of a few different imaging parameters on material density image
concentration measurements were assessed, there are many known sources of variation in
111

QCT that can be expected affect quantitative measurements (6,72,85). For example, there are
many more GSI protocols, with many different associated imaging parameters, which have
unknown effects on material density measurements. A detailed investigation of the effects of
these parameters would greatly clarify the possible utility of DECT concentration
measurements.
A more sophisticated calibration of our K2HPO4 concentration measurements to HA density
may have allowed for a better comparison to DXA aBMD. This could have been accomplished
with a greater number solid phantoms consisting of varying concentrations of HA in waterequivalent plastic. A programmed basis pair of HA-water may also have been evaluated. These
calibration methods can be explored in future studies.
Finally, additional insight may be gained by performing material density image
measurements in real human vertebral bones, either from cadavers or in patient studies.
Vertebral specimens from cadavers with intact marrow fat would be especially good for this
investigation, so that the effect of real fat and bone on DECT concentration measurements
could be assessed. Alternatively, patient images with both rsDECT and DXA could be obtained
either in a prospective or retrospective study. Such a study would include patients of different
genders, ethnicities, and age groups to benchmark DECT values against those from DXA,
ideally comparing the change in BMD measured between the two modalities over time. In
addition, the clinical value of separate cortical and trabecular measurements of BMD with
rsDECT could be investigated.
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